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Résumé
L’objectif de ce travail doctoral est d’examiner des mécanismes cérébraux impliqués dans
le traitement d’informations d’ordre émotionnel chez des patients atteints de schizophrénie
avec un regard plus particulier sur une éventuelle différence entre ceux qui présentent un
érnoussement affectif (FA+) et ceux qui en sont dépourvus (FA-). En second lieu, la thèse
propose d’évaluer si la quetiapine (un antipsychotique atypique) peut normaliser ou
modifier les modes d’activation cérébrale impliqués dans ces processus de traitement
d’information émotionnelle. L’affect émoussé peut être défini en tant que déficit de la
spontanéité et de la réactivité affectives; phénomène qui peut être observé et, parfois,
subjectivement ressenti. Il constitue un symptôme cardinal de la schizophrénie. De plus,
l’affect émoussé fait partie des symptômes négatifs dont l’ensemble constitue le syndrome
déficitaire de la schizophrénie, ainsi que le facteur le plus valide de l’évaluation des
symptômes négatifs. À l’aide de l’imagerie par résonance magnétique nucléaire
fonctionnelle (1RMf), nous avons mené trois études.
Première étude: Le but de cette étude est d’examiner les mécanismes soutenant la
résonance émotive dans deux groupes de patients schizophrènes (FA+ N= 13 et FA- N=
11). Nous tentons d’éclairer ces mécanismes en nous référant aux théories des
neurosciences sur le fonctionnement du cerveau basé sur ce que l’on désigne comme les
neurones miroirs (MN). Nous prévoyons que le groupe FA+ ne va pas activer les régions
préfrontales impliquées dans le traitement émotionnel. Par contre, le groupe FA- va activer
ces régions, ce qui témoigne de l’existence d’un système fonctionnel de miroir pour la
résonance émotive confirmée par une activation du cortex pré-frontal. Nous avons ainsi
comparé les deux groupes en utilisant une banque d’images (JAPS= International Affective
Picture System) à l’aide de l’IRMf. Une analyse de type random-efJects, pour les patients
FA- a mis en évidence des régions significatives dans le cortex pré-frontal médian. Les
analyses de corrélation effectuées entre les estimations individuelles des sentiments négatifs
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et des changements du signal BOLD “Blood Oxygenated Level Dependent” ont révélé
l’existence d’une corrélation positive dans le cortex pré-frontal médian. Réciproquement, on
n’a pas noté d’activation significative dans le cortex pré-frontal dans le groupe fA+. Nous
proposons ainsi que la résonance émotive négative induite en regardant passivement des
images négatives puisse être une forme de mirroring. Ainsi que l’on pourrait saisir et
interpréter les sentiments négatifs par l’intermédiaire d’un mécanisme miroir «empathie
émotive en se mettant à la place de l’autre ». Avec les neurones miroirs, l’évolution
humaine a franchi un pas de plus dans le monde de la représentation, en facilitant une
représentation plus abstraite de l’état interne des autres. Par conséquent, nous proposons
que les sujet FA-, relativement au système MN émotionnel (Comportement de résonance)
puissent ressentir des images négatives. Inversement, nous proposons que le
dysfonctionnement objectivé dans le groupe FA+ soit le résultat d’un échec ou d’une
anomalie dans le développement du système MN. Ceci pourrait être dû à des causes
génétiques ou d’autres causes endogènes ayant affecté le système MN du cortex pré-frontal
impliqué dans la résonance émotive.
Deuxième étude: pour tenter de comprendre les différences neurobiologiques entre les
patients schizophrènes avec (FA+ N= 13) et sans (fA-= 11) émoussement affectif (même
patients que la 1êre étude), nous avons scanné pendant un état négatif (neg) puis neutre
(neut) au cours d’un visionnement d’images lAPS, en utilisant l’IRMf. Sur une échelle de O
à $ correspondant au sentiment négatif ressenti pendant la séance d’imagerie, le groupe de
sujets FA+ a exprimé une moyenne de 1±1.52 et le groupe FA- 5.9 ±1.22 (P<O.0001).
Ainsi, une analyse de test T à un échantillon (neg — neutre pour FA+
- FA- et vice-versa) a
montré une activation significative pour le groupe FA- dans le cortex visuel, visuo
temporal, cunéus, pré-frontal médian, orbito-frontal, le cortex cingulaire antérieur,
l’amygdale, l’insula, le mésencéphale et la protubérance . Quant à lui, le groupe FA+ a
activé de manière significative le cortex visuel, la protubérance et le mésencéphale.
L’inactivation relative des régions pré-frontales, orbito-frontales, cingulaires antérieures,
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l’amygdale et l’insula pourraient expliquer le fonctionnement émotif altéré dans le groupe
FA+. Inversement, l’activation significative de ces mêmes régions chez les parents FA-
pourrait signifier que l’altération du fonctionnement émotif soit non pas le symptôme
fondamental de la schizophrénie mais plutôt celui du sous-groupe des patients atteints de
schizophrénie avec émoussement affectif. Nous proposons que les patients FA+ utilisent
une stratégie passive dans la réaction au stimulus négatif en n’activant conséquemment
que la région du mésencéphale. Au contraire, les sujets FA- mettent en oeuvre une stratégie
active permettant la propagation de l’infonuation au cortex pré-frontal.
Troisième étude: L’objectif de cette étude en IRMf était de mesurer l’impact d’un
traitement à la Quetiapine sur le fonctionnement de la circuiterie neuronale sous-tendant
l’expérience de la tristesse chez les sujets schizophrènes souffrant d’un émoussement
affectif. Pendant le visionnement passif des extraits tristes et neutres des films, nous avons
scanné 12 patients (12 des 13 patients des études 1 et 2) avant et après le traitement à la
quetiapine (une médiane de 5,5 mois de traitement avec la quetiapine). Les analyses
‘random-effects’ d’activation de cerveau avant la quetiapine ont indiqué une activation
significative dans le tronc cérébral (protubérance). Après une durée suffisamment longue
de traitement avec la quetiapine, le même contraste a montré une activation prefrontale
(Broadmann “BA” 32, 46) et temporale (BA 38 et l’amygdale) significative. L’activation
des régions prefrontales principales impliquées dans le traitement de l’émotion, de plus,
l’amélioration, significative de symptômes, rnesureé par l’échelle d’évaluation subjective et
le PANSS “Positive and Negative Symptoms Scale” suggèrent un effet potentiel de la
quetiapine dans l’amélioration des symptômes relatifs à l’émoussement affectif (c-à-d.,
retrait passif retrait émotif, évitement) dans la schizophrénie.
L’ensemble des resultats de cette thèse propose que les mécanismes neuronaux sous jacent
au traitement de l’information émotionnelle soient différents entre les deux groupes (FA+
Xet FA-). De plus, la quetiapine joue un role dans l’amélioration de l’affect émoussé dans le
groupe FA+ en agissant sur le circuit mésocortical.
Mots-clés schizophrénie, symptomes négatifs, émoussement affectif émotion,
antipsychotique atypique, quetiapine, résonance magnétique nucléaire fonctionnelle RMNf.
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Abstract
Research suggests emotion abnorrnalities to be a highly prevalent symptom of
schizophrenia. Such studies argue for a “unitary” based model for schizophrenia. However,
we advocate that no “unitary” model is likely to account for the multiplicity of
schizophrenia symptomatology. Our study attempts to further test this by comparing
schizophrenia patients with (FA+) to without (FA-) flat affect, thus investigating the true
neurobiologically based heterogeneity that goes beyond any one dysfunctional circuit
(model). Furthermore, we investigate quetiapine as a potential treatment for schizophrenia
patients (FA+). To that end, we conducted the following three studies using functional
magnetic resonance imaging (fiVIRI). first study: The aim of this study was to use
neuroscience theories about brain function (mirror-neurons IVIN) to draw inferences about
the mechanisms supporting emotional resonance in two different groups of schizophrenia
patients (FA+ n=13 and FA- n=1 1). We hypothesize that FA+ will not activate key brain
areas involved in emotional processing. Conversely, FA- will have a functional mirror
system for emotional resonance confirmed by activation of the prefrontal cortex and
behavioral resuits. To test this hypothesis, we compared the 2 groups using blood
oxygenation level dependent (BOLD) fMRI during a passive visual task (44 negative lAPS
pictures and 44 neutral pictures). A random-effects ana1ysis for schizophrenia patients FA-,
revealed significant loci of activation in the left medial prefrontal (LMPFC), right
orbitofrontal (ROFC) and left anterior cingulate cortices (LACC). Correlational analyses
carried out between self-report ratings of negative feelings and BOLD signal changes
revealed the existence of positive correlation in the LACC, LMPFC and ROFC.
Conversely, FA+ did flot show significant activation in the prefrontal cortex. We propose
that negative emotional resonance induced by passively viewing negative pictures may be a
form of “mirroring” that grounds negative feelings via an experiential mechanism. Hence,
it could be argued that FA- were able to ‘feel’ emotions through this resonance behavior.
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Conversely, we suggest that the dysfunction seen in the FA+ group is a failure or distortion
in the development of the MN system. This could be due to genetic or other endogenous
causes, which affected prefrontal cortex Iv1N involved in ernotional resonance. The second
study: The aim of this fMRT study was to compare regional brain activity in schizophrenia
subjects with (FA+) and without (FA-) flat affect during the viewing of emotionally
negative pictures. Thirteen FA+ subjects and eleven FA- subjects were scaimed while being
presented with series of emotionally negative and neutral pictures. Experientially, the
viewing of the negative pictures induced a negative emotional state whose intensity was
significantly greater in the FA- group than in the FA+ group. Neurally, the Negative minus
Neutral contrast revealed, in the FA- group, significant loci of activation in the midbrain,
pons, anterior cingulate cortex, insula, ventrolateral orbitofrontal cortex, anterior temporal
pole, amygdala, media! prefrontal cortex, and extrastriate visual cortex. In the FA+ group,
this contrast produced significant loci of activation in the midbrain, pons, anterior temporal
pole, and extrastriate visual cortex. When the brain activity measured in the FA+ group was
subtracted from that measured in the FA- group, only the lingual gyrus was significantly
activated. Perhaps in FA+ subjects an amygdaloid malfunction rendered the amygdala
unable to correctly evaluate the emotional meaning of the pictures presented, thus
preventing effective connectivity linking the amygdala to the brain regions implicated in
the physiological and experiential dimensions of emotion. Alternatively, a disturbance of
effective connectivity in the neural networks linking the midbrain and the medial prefrontal
system could be responsible for the quasi absence of emotional reaction in FA+ subjects,
and the abnormal functioning of the medial prefrontal cortex and anterior cingulate cortex
in the FA+ group. The third study: BOLD brain changes underlying response to quetiapine
were examined using passive viewing of emotionally aversive and neutral stimuli. Twelve
DSM-W schizophrenia patients with flat affect/ernotional withdrawal (FA+) (positive and
negative symptoms scale + rating scale for emotional blunting) were scanned before and
afier 5.5 months of quetiapine treatment. Whole-brain, voxel-based methods were used to
assess response-specific quetiapine effects. A post-hoc comparison to an independent group
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of 11 schizophrenia patients without flat affect/social withdrawal (FA-) was also performed
to interpret the specificity of identified quetiapine effects. A 5.5-month treatment with
quetiapine resulted in significant clinical improvement in the 12 study completers (mean
±SD post-treatment PANSS flat affect score of 5.50 ±0.76 at baseline to 2.08 ±1.00 at end
point (t=7.7$, df=11, p<O.000l). Treatrnent response was associated with significant BOLD
changes both in sub-cortical an cortical structures: increases in prefrontal cortex activation
right dorsolateral prefrontal (DLPFC, BA 46) and the right anterior cingulate cortex (ACC,
BA 32); left putamen, right anterior temporal pole (ATP) and right amygdala. Conversely,
before quetiapine, the same subjects activated only sub-corticat structures: the midbrain
bilaterally and the right pons. The post-hoc conjunctional analyses demonstrated that FA
subjects activated the left ACC, left insula, left ATP (BA 21), left ATP (BA 3$), lefi
amygdala and right medial prefrontal cortex. Quetiapine seems to affect clinical recovery
by modulating the functioning of specific sites from subcortical to cortical regions (i.e.,
modulating the mesocortical pathway). Unique 3OLD changes in the putamen and DLPFC
with quetiapine, in the FA+ post-quetiapine, relative to other drugs (used by FA-) may
reflect modality-specific effects with implications for understanding flic neural correlates
underlying different treatment mechanisms. In summary, it should be noted that we do not
suggest that there are categorical subtypes of schizophrenia patients based on the with flat
affect/without flat affect symptomatology. However, our findings, demonstrating
differential haemodynamic flow between schizophrenia patients with and without flat
affect, mean that the quest for the symptorn-specific-neuropathology of schizophrenia could
help explain the multiplicity of neuro-circuit dysfunction in this heterogeneous disorder.
Furthermore, we suggest quetiapine could have a role in improving flat affect/emotional
withdrawal symptoms in schizophrenia patients.
Keywords : schizophrenia, flat affect, emotions, functional magnetic resonance imaging,
visual cortex, midbrain, amygdala, prefrontal cortex.
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1Introduction
1. Schizophrenia
“The singular indfference of the patients towards their former emotional relations, the
extinction of affection for relatives andfriends, ofsatisfaction in their works and vocation,
in recreation andpleasures, is miot setdom thefirst and rnost strlldng symptom ofthe onset
of disease. The patients have no real joy of lfe, “no human feelings “, to themn “nothing
matters, evetything is the sarne”; theyfeet “no grief and nojoy’ their heart is flot in what
they say” (Kraepelin, 1919).
The above words emphasize the fact that schizophrenia is one of the most debilitating
brain disease, damaging what we regard as specifically human. It is one of the most
important public health problems. Among psychiatric disorders, the combined economic
and social costs place schizophrenia among the world’s top ten causes of disability-adjusted
life-years (Murray and Lopez, 1996). Schizophrenia typically has its onset between the
ages of 16 and 30 years. It usually has a gradual, insidious onset taking place over an
average of 5 years (D$M W). Outcomes are currently of interest in health-econornics
research; probably no other chronic illness parallels schizophrenia in the potential for poor
functional outcome in the absence of a measurable decrease in lifespan, which is a
substantial burden ofmorbidity. Noteworthy, approximately 10-15% commit suicide (Ho et
al., 1997; Lewis and Lieberman, 2000).
2Schizophrenia is a life-long disorder characterized by three broad types of symptoms:
(j) Psychotic/positive syrnptoms involving the loss of contact with reality, including false
beliefs (delusions), perceptual experiences flot shared with others (visual, auditory, tactile
and gustatory hallucinations), hostility, paranoid ideation. (ii) Negative syinptoms
including flat affect, emotional withdrawal, passive/apathetic social withdrawal, anhedonia
(lack of pleasure), avolitionlapathy (diminished ability to initiate and follow through on
plans), and alogia (reduced speech). (iii) Cognitive symptoms including unusual thought
content, poor attention, lack of judgment and insight, difficulties in abstract thinking,
memory and problem solving (based on the DSM-W description). 0f particular relevance
to our study, these various symptoms are present in schizophrenia patients in pattems that
may not overlap at all. One person may have delusions without presenting any flat affect
symptoms, while another may have hallucinations and anhedonia. From a
pathophysiological view, this non-overlapping pattem of symptoms raises some questions:
is there a core or single brain circuit that unites schizophrenia as a single disease or
different brain circuits depending on the symptom(s) present? In other words, could the
brain circuit dysfunction vary according to symptoms? What is the relationship, on a neural
circuit level, between a patient who had poor premorbid socioemotional adjustrnent, then
develops schizophrenia with a marked flat affect symptom and a patient who had normal
socioemotional adjustment, then develops schizophrenia with bouts of positive psychotic
symptoms without any trace of flat affect?
32. Diagnosis of schizoplirenia
From a criterion-based view, schizophrenia symptoms are grouped into a single disease
using a purely descriptive approach using clustering of symptoms. Criterion-based systems
have been developed to decrease the complexity and improve the reliability of diagnosis.
These systems include the International Classification of Diseases, tenth edition (lCD- 10)
(1994), and the Diagnostic and Statisticai Manual of Mental Disorders, fourth edition
(DSM-W) (1994), which describe characteristic symptoms of schizophrenia (it is the most
widely used). In lCD-10, severe symptoms should have been present for 1 month, whereas
in DSM-W, 6 months’ duration is required (ie, including less severe prodromal and
residual symptoms). The DSM-W criteria also require deterioration in social and
occupational functioning, specified as dysfunction in work, interpersonal relations, or self
care. Other diagnoses, such as mood disorders with psychotic features, must be ruled out
and symptoms must be shown to be due to no other medical disorder or drug effect, such as
steroid-induced or amphetamine-induced psychosis. Noteworthy, diagnostic criteria
improve reliability, enable standardization across centers, nationally and internationally,
improve clinicai communication, and facilitate research. However, these criteria should not
discourage innovative thinking about the fleurai mechanisms of schizophrenia. Rather, they
should be combined with symptom-rating scales, ciinical experience and new techniques to
better define features ofthis disorder that may respond to various therapeutic interventions.
4Unfortunately, with their emphasis on psychotic symptoms (delusions, hallucinations,
etc...), criterion-based approaches may have neglected other symptoms. for example,
social deterioration commonly becomes prominent before and persists afier the more severe
symptoms (positive symptoms) have been controlled with medication. These symptoms
resuit in impaired functioning in interpersonal relationships. Most commonly, people who
have schizophrenia are unable to continue in employment or education. Fortunately,
presently psychosocial impairment is being studied as an important outcome measure, and
is becoming the focus of treatment. In addition, psychiatrists are increasingly recognizing
the correlation between negative symptoms and loss of social ftmnction arnong
schizophrenia patients. Alogia, avolition, apathy, flat affect, etc... are among these negative
symptoms, which lead to long-term social and economic burden because patients cannot
maintain productive employment (Green, 1996). It should be noted that negative symptoms
are the Ieast likely to improve over the course of illness, and resulting cognitive dysfunction
in the context of these symptoms is most likely to contribute to unemployment (Pogue
Geile and Harrow, 1985). Hence, a better understanding of negative symptoms and the
development of effective treatments are required.
Moreover, negative symptoms are known to occur long before the onset of fond
psychosis (positive symptoms) in schizophrenia patients (Strauss et al., 1973). However,
the emphasis on psychosis as a hallmark of schizophrenia has lcd to conceptualizing the
early impairments, i.e. negative symptoms, as premorbid. It is imperative to determine
5whether such impairments are premorbid, early manifestations of the disease or a
schizophrenia subtype, under-diagnosed until the manifestation of positive symptoms.
Indeed, schizophrenia, simplistically, couïd be viewed as a whole-brain disease. However,
with its extremely diverse but interlocking neural circuit pathologies and symptoms, more
research is needed using a true neurobiologically symptom-based models.
3. Pathogenesis and Pathophysiology: focus on abnormal brain circuits connectivity
and neurodevelopmental theories
0f the thousands of associative threads that guide our thinking, this disease seerns to
interrupt, quite haphazardly, sometimes single threads, sometirnes a whole group, and
sornetimes whole segments ofthem... the thousands ofassociations guiding oui- thought are
interrupted by this disease. . . the thought processses, as a resuit, become strange and
illogical and the associationsfind newpaths” Bleuler, 191].
These words should humble the modem neuroscientists, neuropathologists and
neuropsychiatrists investigating the relationship between brain circuits misconnectivity
andlor dysfunction and the phenomenology of schizophrenia. Bleuler’s prophetic words
have currently their counterparts in modem neuropsychiatry, which have implicated
aberrant functional connectivity (miswiring) between different brain regions as the
pathophysiological mechanism of psychosis. However, although some insights into the
etiology of schizophrenia have been developed, an understanding of the illness remains
6elusive. One could say that Bleuler’s (1950) use of the term “group of schizophrenias” was
insightful and prophetic.
In an attempt to understand schizophrenia, Weinberger (1995) reviewed the possible
causes including: rhesus (Rh) factor incompatibility, perinatal/prenatal viral infections,
obstetrical complications, hypoxia at birth, famine and malnutrition, severe environmental
stress, the epidemiologic risk factors of urban and winter birth and heritability as
demonstrated by twin and adoption studies. A number of abnormalities have been identified
and confirmed by meta-analysis, for example, ventricular enlargement, which is
accompanied by decreased cortical and association neocortical (prefrontal and superior
temporal) and hippocampal volumes (Harrison and Weinberger, 2005).
Noteworthy, these abnormalities are characteristic of schizophrenia as a whole, rather
than being restricted to a subtype, and are present in first-episode, unmedicated patients.
These morphometric changes are in tum suggestive of alterations in synaptic, dendritic and
axonal organization. Generally, it is hypothesized that the interaction of genetic and early
neurodevelopmental insuits result in defective connectivity between a number of brain
regions, including the midbrain, nucleus accumbens, thalamus, temporolimbic
(hippocampus), and prefrontal cortices (Selemon and Goldman-Rakic, 1999) leading to
schizophrenia symptomatology. In this context, combinations of genetic and environmental
factors may affect various neural circuits within the brain leading to diverse symptoms. The
7insuit (genetic and!or environmentai) may hit one site and then flow across several fleurai
circuits.
These changes tend to link schizophrenia with connectivity and communication
disruption within the fleurai circuitry (for a complete review McGlashan and Hofffian,
2000). This defective neural circuitry is then vuinerable to dysfunction when unmasked by
the developmental processes and events of adolescence (myelination, synaptic pruning, and
hormonal effects of puberty) and/or exposure to stressors as the individual moves through
the age ofrisk (Lewis and Lieberman, 2000).
Relatedly, Jones (1995) proposed, based on neuroanatomical and gene expression
studies, that a disturbance of migration or in the pattem of preprogrammed celi death in the
subplate zone of the developing cerebral cortex causes a failure to establish normal patterns
of connections in the overiying cortex. Consequently, this could lead to schizophrenia
symptoms and activity-dependent manifestations of altered gene expression for
neurotransmitter- and receptor-related molecules. Jones (1997) showed that the number of
neurons in the cortical subplate (the white matter irnmediately below layer VI of the cortex,
a transitional structure that plays a key role in the formation of connections in the cerebral
cortex), is reduced in the preftontai and temporal lobe cortices, whereas their number in the
white matter deeper than 3 mm from the cortex is significantly greater compared with
normal subjects. In addition, Jones (1997) ffirther suggested that the loss of ceils in the
8thalamus may be primary or secondary to cortical or other subcortical pathology. Loss of
thalamic celis andlor of corticothalamic inputs could lead to disintegration of thought
processes by a failure in functional brain states dependent on collective oscillation of large
ensembles of cortical and thalamic fleurons. Structural or functional defects of the
thalamus, because it is associated with filtering sensory information and gating
mechanisms, may be particularÏy important in the pathogenesis of schizophrenia; indeed,
problems of information filtering may underlie disturbed thought processes.
Evidence suggesting that schizophrenia symptoms are flot caused by dysfunction of a
single brain region came based on empirical data derived from both magnetic resonance
and positron emission tomography. Andreasen et al., (1998), developed a model that
implicates the cortico-cerebellar-thalamic-cortical circuit (CCTCC) connectivity in
schizophrenia symptomatology. The authors concluded that a dysffinction in this circuitry
produces “cognitive dysmetria”, difficulty in prioritizing, processing, coordinating and
responding to information, a disruption of the fluid, coordinated sequences of thought and
action that are the hallmark of normal cognitive functions.
Furthermore, interesting morphometric findings in the dorsolateral prefrontal cortex
(Broadmann areas 9 and 46) have uncovered a form of cortical pathology in schizophrenia
in which poor neuronal activity/connectivity appears to correlate with cognitive dysfunction
(Selemon and Rajkowska, 2003) and the reduced neuropil hypothesis (Selemon and
9Goldman-Rakic, 1999). The reduced neuropil hypothesis advances a circuit based model of
schizophrenia proposing that a reduction in interneuronal neuropil in the prefrontal cortex is
a prominent feature of cortical pathology. The authors suggest that this neuropathology is
of subtie changes in cellular architecture and brain circuitry that nonetheless have a
devastating impact on cortical function. They report that the increased neuronal density
seen on histological examination as reduced neuropil without neuronal loss, point towards
loss of connections between neurons.
Recently, a review by McGlashan and Hoffhian (2000) formulated a
pathophysiological model of schizophrenia according to postmortem and neuroimaging
findings. The authors proposed that schizophrenia resuits from developmentally reduced
synaptic connectivity (DRSC). The model posits that schizophrenia arises from critically
reduced synaptic connectivity as a result of developmental disturbances of synaptogenesis
during gestation and early childhood andlor synaptic pruning during adolescence. The
DRSC model identifies reduced synaptic density in prefrontal and other areas of association
cortex as the “final common pathway” to the symptoms and course of schizophrenia.
However, before this “final common pathway” mild dysfunctions associated with
these early neurobiological lesions occasionally emerge as vulnerability factors or risk
markers for schizophrenia. For example, diminished expression of positive and negative
emotions, passivity, social withdrawal, and poor relationships (Grimes and Walker, 1994;
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Hans et al., 2000), neuromotor abnormalities in the form of poor coordination, poor
perceptual motor integration, or abnormal speech (01m and Mednick, 1996), as well as
minor physical anomalies (Whitty et al., 2003), and neurocognitive deficits (01m and
Mednick, 1996). Noteworthy, such deficits are flot sufficient to produce schizophrenia.
further evidence of neuronal circuit dysfunction in schizophrenia, has corne from studies
investigating eye tracking. Jndeed, smooth pursuit eye movement (SPEM) abnormalities are
associated with liability for schizophrenia (Ross et al., 2002). Relatedly, in a recent article
by Hong et al., (2005), the authors stated that understanding the neurophysiologic
rnechanisms underlying SPEM deficits is likely to enhance our ability to refine them as
endophenotypes for genetic studies. Hong and colleagues have compared pursuit-related
brain activation in schizophrenia patients and healthy control subjects, matching subjects on
average maintenance pursuit performance. Patients showed decreased activation compared
with healthy subjects in the medial superior temporal cortex, frontal eye field, and
suplementary eye field areas hypothesized to be involved in extraretinal motion processiiig.
However, they have showed increased activation Brodmann areas 19 and 37. These
correspond to posterior retinal motion regions and are consistent with the notion that a
portion of the individuals who possess liability for schizophrenia rely more on retinal
signais to maintain pursuit
Overail, rather than having a distinctive diagnostic neuropathology, schizophrenia
seems to consist of quantitative alterations in various normal parameters of neural
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microcircuitry. In this vein, because of a lack of definite neuropathology, schizophrenia
remains a clinical diagnosis based on the presence of positive and negative symptoms.
Therefore, and since schizophrenia is a heterogeneous brain disease, understanding the
functional abnormalities of different brain circuits and relating this to symptomatology is of
primordial importance in our quest to understand schizophrenia.
4. Schizophrenia sub-types and Negative symptoms: focus on Flat affect
In 1857, John Russeil Reynolds stated “Many of the symptoms of disease are merely
modified vital actions.. .some symptoms are negative, i.e., they consist in the negation of
vital properties. . .other symptoms are positive, i.e., they consist in the excess of alteration
of vital properties”, hence introducing the concept of negative versus positive symptoms to
schizophrenia (Berrios, 1985). Insightfully, John Hughlings Jackson (1875, 1889) described
negative symptoms as the diminution or negation of normal processes, resulting from tissue
destruction; and positive symptoms as the excess in normal brain processes as disinhibiting
consequences ofthis tissue destruction. Going one step further, Kraepelin (1919), reported:
• .there are apparently two principal groups of disorders which characterize the malady.
On the one hand we observe a weakening of those emotional activities. . .The result of this
part of the morbid process is ernotional dullness. Bleuler (1911) considered negative
symptoms to represent “fundamental” or core psychopathologies in schizophrenia. He
defined schizophrenia as essentially a spiitting of thoughts (cognition) from feelings
(emotion). More recently, many attempts to subtyping schizophrenia have emanated. I will
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briefly outline the main six. First, in 1974, Tsuang and Winokur proposed the paranoid
(delusions, hallucinations) versus the nonparanoid (flat affect, disorganized thoughts)
subtypes. Then, in 1980 the concept of Type I and Type II schizophrenia was introduced by
Crow (1980a). This subdivision put greater emphasis on the presence or absence of
negative symptoms, with poverty of speech and flat affect defining the presence of the
negative syndrome (Type II) and the prominance of psychotic symptoms for the positive
(Type I) syndrome. Third, came Andreasen and Olsen (1982), who conceptualized positive
(delusions, hallucinations, hostility) and negative symptoms (affective flatting, alogia,
avolition-apathy, anhedonia-asociality, and attentional impairment) as different ends of the
same continuum and described patients as either predominantly positive or predominantly
negative. Farmer and colleagues (1983) were fourth to propose the P type (delusions, late
onset) versus the H type (flat affect, bizarre behavior, incoherent speech and early onset)
distinction. fifth, Liddle and collaborators (1987) introduced the concept of the three
syndromes: psychomotor poverty (poverty of speech, lack of spontaneous movement and
various aspects of blunting of affect); disorganisation (inappropriate affect, poverty of
content of speech, and disturbances of the form of thought); and reality distortion
(particular types of delusions and hallucinations). Sixth, in an effort to clarify the situation,
the deficit/non-deficit distinction was put forth by Carpenter and colleagues (198$). They
identified six negative symptoms (i.e., poverty of speech, diminished emotional range, flat
affect, diminished sense ofpurpose, curbing ofinterests and diminished social drive) as the
deficit syndrome. In this vein, Kirkpatrick and colleagues (2001), stated that the
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deficit/non-deficit schizophrenia sub-groups differ in their signs and symptoms, course,
biological correlates, treatment response, and etiologic factors.
In 1980, Crow hypothesized that negative symptoms (poverty of speech, flat affect)
in schizophrenia represent a behavioral syndrome that was the manifestation of unspecified
structural brain abnormalities. It should be noted that researchers seeking to establish
different etiologies for the positive and negative subtypes struggled with the degree to
which the sutypes are truly different because they have found overlap cross-sectionally and
longitudinally. Other researchers made the attempt to delineate the defective brain circuits
based on biochemical hypotheses. In this vein, the implications of several
neurotransmitters have been proposed: GABA, glutamate, serotonin, achetylcholine,
noradrenaline (for a full review see Stahl, 2002). However, the classical comerstone theory
to explain schizophrenia is the ‘dopamine hypothesis’, proposing that the positive
symptoms of schizophrenia are related to dopamine neurons overactivity in the mesolimbic
pathway, and that the negative symptoms are related to underactivity of dopamine input to
the prefrontal cortex (Weinberger and Wyatt, 1982).
from the above, we should note the emphasis on the role flat affect plays in
schizophrenia. Kraepelin (1919) conceptualized affective deficits as fundamental symptoms
of schizophrenia. Importantly he gave particular emphasis to diminished emotional
experience. More recently, numerous other authors have also advocated the role emotional
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deficits play in schizophrenia. For example, Crow (1985) used poverty of speech and flat
affect as the key symptoms for the definition of a negative symptom subtype because these
are the symptoms that are both primary and enduring.
In support of Kraepelin’s early observation on the role emotional dullness (flat affect)
plays in schizophrenia, contemporary research lias provided converging evidence about its
diagnostic and prognostic importance (Abrams and Taylor, 1978; Sweet et al., 199$; Gur et
al., 2002). flat affect has also been shown to be a relatively enduring symptom that
generally responds poorly to treatment (Pogue-Geile and Harrow, 1985). it is important to
note that patients with schizophrenia exhibit impairments in emotional discrimination and
experience across cultures (Habel et al., 2000). furthermore, the presence of this symptom
is related to poor clinical outcomes on several dimensions, including employment (Pogue
Geile and Harrow, 1985), social functioning (Breier et al., 1991), and severity of illness
(Abrams and Taylor, 1978). Moreover, premorbid affective blunting is associated with an
earlier onset of illness and poorer prognosis in schizophrenia (Grimes and Walker, 1994). A
great body of evidence suggests that diminshed expression of positive and negative
emotions, passivity, social maladjustments, anxiety, withdrawal and poor peer relationships
are the clearest prodromal symptoms leading to the onset ofpsychosis (Watt, 1978; Done et
al., 1994; Ingraham et al., 1995; Mirsky et al., 1995; 01m and Mednick, 1996). Although
research has given greater insights into the impact of flat affect and the nature of the deficit,
the pathophysiology and causes are still not clearly understood.
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4. Explauatory models of flat affect (affective deficits) in schizoplirenia
Explanatory models of flat affect have proposed various etiologies, invoking
psychodynamic processes such as repression (Arieti, 1955; Pao, 1979), emphasizing the
role of impaired social relations and social rejection (Roff and Knight, 1978). A recent
hypothesis has suggested that flat affect is the manifestation of dysfunction in the right
hemisphere (Mayer et al., 1985). The potential significance ofright hemisphere dysfunction
in flat affect derives from evidence obtained in neurologie populations with cortical lesions.
These patients have been described as showing flat affect or emotional indifference that is
strikingly similar to the clinical picture of flat affect seen in schizophrenia. Whittaker and
colleagues (1985) reported associations between frontotemporal dysfunction and impaired
perception of both facially expressed and vocally expressed emotion. Another more recent
hypothesis proposed dysfunction of the frontal lobe areas (Gur et al., 2002; Weinberger,
1987; Buchsbaum, 1990; Weddell et al., 1990; Mega and Cummings, 2001), because of
their afferent and efferent connections with limbic structures, which have been implicated
in affective behavior. Interestinsly, Takahashi et al., (2004) proposed that schizophrenia
patients might have relatively intact function of conscious processing of significant
emotional information, leading to a categorization of emotional pictures similar to that of
controls, however, they have impairment in the rapid, automatic processing of salient
stimuli. In other words, patients could assign significance to stimuli through conscious
processing, but they might have diminished automatic emotional response to extemal
stimuli.
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5. Studies in support of affective deficits ïn schïzophrenia
Affective deficits in schizophrenia can be identified in three general domains
(reviewed in Limpert and Amador, 2001): 1) deficits in the perception of emotion (i.e.,
difficulty judging and interpreting the emotional displays of others), 2) deficits in the
expression of emotion (i.e., difficulty conveying one’s emotional experience to others) and
3) deficits in the experience of emotion (i.e., difficulty with the subjective feeling of
emotion). In this study, we have focused on the latter, with some involvement of the first
(i.e., in order to feel we need first to perceive and interpret the emotional displays).
The greatest amount of empirical work, investigating emotion deficits in
schizophrenia, has been conducted in the areas of emotion perception and emotion
expression, with few studies investigating emotional experience. A number of studies
examining interpersonal behaviors in flat affect have focused on either self-report of
interpersonal behaviors (Habel et al., 2000; $ison et al., 1996) or have used a behavioral
approach to study these behaviors, such as assessing eye contact, verbal comments, and
body gestures (Sweet et al., 1998; Kohler et al., 2000; Alpert et al., 2000; Alper et al.,
2002). further evidence cornes from studies reporting that schizophrenia patients are
impaired in judging various facial expressions depicted in photographs (for example,
Cutting, 1981; Heimberg et al., 1992). Several studies also provide evidence for a deficit in
judging vocal expressions ofemotion in schizophrenia patients (Borod et al., 1990; Haskins
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et al., 1995). 0f particular note, the deficits appear to be less consistent, across studies and
populations, when using observer ratings. These equivocal findings may be due to the fact
that flat affect schizophrenia patients tend to be negatively evaluated andlor negatively
evaluate their social skills. Altematively, the faulty interpersonal responses may be too
subtie to be reliably detected using a behavioral approach, which usually involves
videotaping social responses and later quantifying the responses using a coding system.
This approach can be problematic because the behavioral coding systems may flot be those
behaviours that are most critical to the social/emotional interaction. furthermore,
social/emotional interactions consist of capturing nuanced behaviors (e.g. slight curve of
the hp, subtie flare of the nostril) that may be difficuit to capture using behavioral coding
systems.
For this reason, a second approach to measuring sociah/emotional disphays was put
forth: to employ physiological indices, such as facial electromyography (EMG) (Sison et
al., 1996; Iwase et al., 1999; Kring et al., 1999). The authors found that increased
bluntedness of affect was associated with longer pauses and reduced dyadic interaction and
less zygomatic (cheek) electromyogram activity. The flat affect patients unexpectedly
showed more corrugator (brow) electromyogram activity compared with control groups,
which perhaps reflects difficuhty in self-expression. Furthermore, schizophrenia patients
showed reduced zygomaticus activity (EMG) during both the happy film and the interview,
suggesting a reduced ability to express happy facial expressions, such as smiling, in the
1$
lower face (Mattes et al., 1995). However, there remains the question: what happens in the
brain?
The answer of this question lies in the third and more recent approach, the one we
will be focusing on: functional neuroimaging. Functional magnetic resonance imaging
(fiVIRI) is a noninvasive technique for measuring changes in cerebral blood flow and
oxygenation that reflect the underlying neuronal activity. This technology offers a powerful
method for exploring three ofthe outstanding questions in schizophrenia research (1) neural
circuits abnormalities in schizophrenia and their associated symptoms; (2) how these neural
circuit dysfunction relate to the heterogeneity of schizophrenia; and (3) how could the
widely accepted single unitary mode! for schizophrenia account for the widespread
functional deficits. Thus, numerous researchers have also introduced, albeit with different
rnethodology, neuroimaging techniques to investigate the neural process of emotional
deficits in schizophrenia. Since 1981, more than 100 articles on functional brain imaging in
schizophrenia have been published. Positron emission tomography (PET) and single photon
emission computed tomography (SPECT), which measure regional cerebral blood flow
(rCBF) and/or metabolisrn, reveal a number of abnormalities and deficiencies in people
with schizophrenia, compared with healthy subjects. A consistent finding (in two-thirds of
the published PET or $PECT studies) is a lower level of prefrontal cortical metabolism in
schizophrenia subjects (reviewed by Wu et al., 2000). Furthermore, many studies have
reported in schizophrenia patients structural and functional abnormalities in the medial
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prefrontal cortex, orbitofrontal and anterior cingulate gyrus, regions important in the
effortful regulation of affective states and emotional behavior (reviewed in PhiÏlips et al
2003).
Consistent with the theory, these studies have suggested that individuals with
schizophrenia may be disturbed not only in their experience andlor expression of affect, but
also in their ability to recognize emotions expressed by others (Gur et al., 2002; Schneider
et al., 1998; Jobnston et al., 2001; Paradiso et al., 2003). In these studies, the main modality
for receiving emotional information was visual, specifically facial expressions. For
example, $chneider and coïleagues (Schneider et al., 1998) found that unlike controls,
schizophrenia patients have not demonstrated amygdala activation during sadness despite
matched ratings to normal controls indicating a similar negative affect. At that time, their
results provided new evidence of functional abnormalities in the limbic system of
schizophrenia patients processing emotions. Crespo-Facorro and colleagues (Crespo
Facorro et al., 2001) PET study reveals an interesting paradox. Schizophrenia: patients
appear to have a normal ability to experience unpleasant emotions, coupled with an
impairment in the ability to experience pleasant ones, and the more psychotic they are, the
greater the acuity of their ability to recognize unpleasantness. At the neural level, patients
with schizophrenia who subjectively rated the unpleasant odor the same as did healthy
volunteers failed to recruit the subcortical limbic and paralimbic structures that would
normally be used for this task. Instead, their normal behavioral response was associated
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with abnormally increased rCBf in a widely distributed group of frontal cortical regions.
On the other hand, these patients had difficulty identifying the positive emotional valence
of the pleasant odors, despite the fact that they gave intensity ratings within the normal
range. Accordingly, the authors concluded that abnormalities in the complex functional
interactions between mesolimbic and frontal regions may underlie emotional disturbances
in schizophrenia. In a more recent fMRI study, Gur and colleagues (2002), found that
schizophrenia patients failed to activate limbic regions during emotional valence
discrimination tasks. Another fMRI study Kosaka and colleagues (Kosaka et al., 2002),
reported that negative face discrimination activated the bilateral amygdalae in the
schizophrenia group whereas the right amygdala alone in the control group. The authors
argued that exaggerated amygdaïa activation during emotional intensity judgment found in
the schizophrenia patients may reflect impaired gating of sensory input containing emotion.
More recently, Takahashi and colleagues (2004), instructed the subjects ( 5
schizophreniall 5 controls), to indicate how each of the presented pictures made them feel.
Whole brain activities in response to the affective pictures were measured by fMRI.
Controls recruited the neural circuit including amygdaloid-hippocampal region, prefrontal
cortex, thalamus, basal ganglia, cerebellum, midbrain, and visual cortex while viewing
unpleasant pictures. However, the patients showed less activation in the components of this
circuit. Furthermore, an elegant study by loannides and collaborators (2004), provided
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evidence for disturbances in functional connectivity in schizophrenia patients, while
processing of facial information.
Together, these studies provide substantial support for a socio-emotional deficit in
schizophrenia (Sweet et al., 1998; Sison et al., 1996; Kohler et al., 2000, Cutting, 1981;
Feinberg et al., 1986; Gessier et al., 1998; Heimberg et al., 1992; Archer et al., 1992).
Reduced facial expression during social interaction (Krause et al., 2003) and diminished
expressiveness in response to emotional films (Berenhaum and Oltmanns, 1992) have also
been reported. According to Lee and colleagues (Lee et al., 2004) disturbances in socio
emotional cognition may represent an abnorrnal interaction between frontal lobe and its
functionally connected cortical and subcortical areas.
In summary, substantial evidence supports emotional deficits and, hence, advocates a
unitary model to schizophrenia (present in ail schizophrenia patients). However, from a
clinical point of view, these symptoms are heterogeneous among schizopbrenia patients.
Thus, studies shouid seek to explore the heterogeneity of socio-emotional dysfunction
within schizophrenia.
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6. Studies contradicting affective deficits in schizophrenia
fi the preceding section, we examined emotional deficits in schizophrenia and
reported some of the data that have been pubiished to support it. We now tum to the issue
that gave rise to our study. Notwithstanding these studies (see previous section), emotional
deficits appear to be inconsistent across studies and populations (Kring et al., 1999; Eamst
and Kring 1999). Overail, studies to date have produced contradictory and inconclusive
resuits (Edwards et al., 2002). fi their review, Mon-ison and colleagues (1988) reported
some conflicting observations among schizophrenia patients in emotion recognition and
experience. They proposed that task or rnethodology differences, are likely to explain the
inconsistent resuits.
First, many studies include chronic patients without the use of comparably ill
psychiatric controls or no psychiatric controïs at ail. Participants have been hospitalized
continuously for Iengthy periods, thus being subject to social isolation. Hence, it would be
worthwhile to study patients with first-episode psychosis to minimize the influence of
variables such as institutionalization. In this vein, Edwards and colleagues (Edwards et al.,
2002) demonstrated that the magnitude of the significant differences between first-episode
psychosis, assessed as outpatients during the early recovery phase of illness, and non-
patients in the recognition of emotion was relatively small, suggesting only a subtie deficit.
There are several studies that demonstrate that phase of illness seems to have an
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effect on emotion recognition, with remitted patients performing better than acute patients
(Gessier et al., 1998).
Second, we should note the lack of attention paid to the long-term impact of
antipsychotic and anticholinergic medications. Paradiso and colleagues (Paradiso et al.,
2003) measured regional rCBF during performance of a task that required
unmedicated patients to recognize the emotional valence of visual images and to
determine whether they were pleasant or unpleasant. When patients consciously
evaluated the unpleasant images, they did flot activate the phylogenetically older fear
danger recognition circuit (e.g., the amygdala) used by the healthy volunteers, although
they correctly rated them as unpleasant. Likewise, the patients showed no activation in
areas of the prefrontal cortex normally used to recognize the images as pleasant and were
unable to recognize them as such. Areas of decreased CBF were widely distributed and
comprised subcortical regions such as the thalamus and cerebellum. Thus, the authors
suggested failure of the neural system used to support emotional attribution consistent with
pervasive problems in experiencing emotions.
Third, to our knowledge, very few researchers have attempted to determine whether
their findings are indicative of schizophrenia patients with flat affect or manifestations of a
more general psychotic process. Investigations would benefit from the inclusion of a
psychotic control group (i.e. schizophrenia patients without flat affect), hence, investigating
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if this ‘subgroup’ exhibits the same deficits. Especially, if we consider studies reporting
that some schizophrenia patients experience emotions (Kring et al., 1999; Berenbaum and
Oltmanns, 1992).
In this section, we summarize a series of investigations that separately reftect the
heretogeneitv ofschizophrenia.
1) Evidence suggests that the paranoid subtype has more intact cognitive functioning
(Morrison et al., 1988), a better premorbid history (Goldstein, 1970), and fewer social
deficits (Strauss et al., 1973) than non-paranoid subtypes. These differences would
suggest that paranoid patients would perform better on tasks of social perception than
non-paranoid patients.
2) Patients with negative symptom schizophrenia have generally been characterized as
having poor premorbid adjustment and lower overali social functioning (Andreasen and
Olsen, 1982; Crow, 1987; Schuldberg et al., 1999) in comparison to patients with
positive symptom schizophrenia. Consistent with this, two studies have found that
paranoid schizophrenic subjects are more accurate than non-paranoid subjects in
judging facial expression of emotion (Kline et al., 1992; Lewis and Garver, 1995).
3) Bryson et al. (1998) found that deficit patients performed more poorly on an affect
recognition test than non-deficit patients, and within the deficit group, diminished sense
of purpose was the deficit symptom most strongly associated with impaired affect
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recognition. Jnterestingly, the deficit patients demonstrated poorer premorbid
adjustment and worse social functioning than non-deficit patients.
4) Blanchard and colleagues (199$) reported less positive affect and significantly greater
negative affect in patients with schizophrenia, compared with controls. The authors
concluded that their findings indicate that schizophrenia is characterized by both
low positive affect and elevated negative affect and that these affective
characteristics are a stable feature ofthe illness.
5) A similar result was obtained by Eamst and colleagues (Eamst and Kring, 1999). In this
article, the authors exarnined emotional responding in deficit patients, non-deficit
patients, and controls, and investigated the importance of the deficit/non-deficit
distinction for studies of emotional responding in schizophrenia. They showed that
deficit patients exhibited fewer outward facial expressions to the films than both non
deficit patients and controls.
6) Noteworthy, in a preliminary report done by our group, we demonstrated no significant
difference between schizophrenia patients without flat affect and normal controls in
emotion processing, using fMRI (fahim et al., 2003).
7) In a recent study, Cohen and Docherty (2004) examined affective reactivity in the
natural speech of schizophrenia patients with and without the deficit syndrome.
Nondeficit patients showed greater affective reactivity of speech than deficit patients.
Conversely, deficit patients’ speech was not more reactive to emotion than the speech of
the control group. These resuits suggest that emotion-related variables mediate the
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relationship between stress and language symptom exacerbations in some patients with
schizophrenia.
Although only few studies investigated emotion deficits between two groups of
schizophrenia patients, the resuÏts mentioned above nonetheless seem to indicate that
whereas schizophrenia patients with severe negative symptoms (flat affect) may have
diminished affective experience, those patients with positive symptoms “feel more”.
Although the latter group of patients may at times show diminished subjective feeling as a
consequence of positive (delusions/hallucinations) or depressive symptoms, this lack of
feeling is flot a stable feature of the illness, as it is for the deficit patients. Overail, these
findings are consistent with the idea that subgroups of schizophrenia patients may differ in
terms of their affective functioning.
7. Psychopli armacological treatments and negative symptoms
The treatment of schizophrenia changed in the 1950s with the discovery of conventional
antipsychotics (typical), such as chlorpromazine and haloperidol. However, patients stili
had incomplete or partial response, with significant negative, more than positive symptoms
remaining despite optimal dosing. In the 1960s, clozapine was introduced as the first
‘atypical’ antipsychotic. Clozapine had a positive effect on both the negative and the
positive symptoms. Nonetheless, it was removed from the market because of its
agranulocytosis. Following this discoveiy, other atypical antipsychotics have been
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discovered. However, the major goal of antipsychotic drug development until the 19$Os
was, stiil, the treatment of positive symptoms. Nonetheless, Crow’s provocative suggestion
(1980a) that chronic schizophrenia patients with negative symptoms were insensitive to
neuroieptic treatment, raised interest in the issue oftreating negative symptoms.
Treating positive symptoms mainly relied on the antipsychotics’ ability to bind to
dopamine-2 (D2) receptors. Indeed, in vitro studies (Seeman et al., 1976; Seeman et al.,
1997) show that ail antipsychotics bind to dopamine-2 (D2) receptors and that the affinity
for the D2 receptor is inversely correlated with the clinical dosage. Although the principal
brain target that ail antipsychotic drugs attach to is the dopamine D2 receptor, traditional or
typical antipsychotics, by attaching to it, induce extrapyramidal signs and symptoms (EPS).
They also, by binding to the D2 receptor, elevate serum prolactin. Atypical antipsychotics
given in dosages within the clinically effective range do not bring about these adverse
clinical effects.
The typical antipsychotics such as trifluperazine, pimozide, chlorpromazine, fluphenazine,
haloperidol, and flupenthixol bind more tightly than dopamine itself to the dopamine D2
receptor, with dissociation constants that are lower than that for dopamine. The newer,
atypical antipsychotics such as quetiapine, remoxipride, clozapine, olanzapine, sertindole,
ziprasidone, and amisuipride ail bind more loosely than dopamine to the dopamine D2
receptor and have dissociation constants higher than that for dopamine (Kapur and Seeman,
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2002; Seeman, 2002). Despite the introduction of these several new antipsychotics,
quetiapine lias several specificities not shared by other atypical antipsychotics, i.e., lower
extrapyramidal symptoms and no hyperprolactinemia (Tauscher et al., 2002). The
pharmacological basis of quetiapine’s low propensity to induce extrapyramidal symptoms
may be explained by its combined antagonism at 5-HT2A and D2 receptors or its fast
dissociation from the D2 receptor (Kapur and Remington, 2001). In this vein, moderate
occupancy of D2 receptors has been proposed to be clinically superior to a more complete
D2 blockade (Meltzer and Gudelsky, 1992). Tauscher and colleagues (2002) reported,
using PET, that in the striatum, the D2 occupancy ranges from 81% for risperidone to 30%
for quetiapine, with the following rank order: risperidone > olanzapine > clozapine >
quetiapine. Kapur et al., (2000) demonstrated, using PET, that quetiapine does give rise to
transiently high (58%-64%) D2 occupancy 2 to 3 hours afier a single dose that then
decreases to minimal levels (< 30%) in 12 hours. In other words, quetiapine’s
pharmacology lias aspects that are consistent with the atypical pharmacologic profile of an
antipsychotic, yet, novel and distinct in its low D2 binding affinity and fast dissociation
from the receptor. In vivo functional studies ail provide evidence that quetiapine has a
preferential effect on limbic as opposed to striatal D2 receptors. EP$ are associated with D2
occupancy in the striatum, whicli therefore predicts a therapeutic effect with placebo levels
ofEPS for quetiapine (Arvanitis et al., 1997).
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A recent review (Lublin et al., 2005) reported that clinical trials suggest that atypical agents
improve negative and affective symptoms, and cognitive functioning more than typical
antipsychotics. 0f particular relevance to our study, quetiapine has a direct effect on the
negative symptoms of schizophrenia (Tandon, 2004). In this study, the author evaluated,
quetiapine’s effect on negative symptoms, from four randomized, controlled clinical studies
involving 1106 patients employing a path analysis model. The total effect of quetiapine on
negative symptoms was measured using the Scale for Assessment of Negative Symptoms
(SANS) total score. Indirect effects on negative symptoms via positive, depressive and EPS
were assessed using appropriate instruments. Effect sizes were calculated by path analysis
for the difference between treatment groups in change from baseline to endpoint in SANS
total score. Analysis confirmed that quetiapine produced a greater overali improvement in
negative symptoms than placebo (effect size 1.96); this was explained by a significant
direct effect (p = 0.001; 44.2% of total improvement), and a secondary effect of improved
positive symptoms (p <0.001; 47.5% of total improvement), but was not a consequence of
changes in depressive symptoms or EPS. Thus, the author concluded that quetiapine has a
substantial direct effect on improving the negative symptoms of schizophrenia. In addition,
in animal studies, quetiapine has been shown to reverse amphetamine-induced social
isolation in monkeys (an animal model for the negative symptoms (Ellenbroek et al., 1996).
In this vein, chronic administration of quetiapine reverses the inhibitory effects of
amphetamine on midbrain dopamine neurons and produces depolarization inactivatioin of
limbic-related AlO dopamine neurons (Goldstein et al., 1993).
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finally, worth mentioning, a fundamental problem in schizophrenia treatment is the
traditional view of schizophrenia as a disease entity rather than a syndrome comprising
several pathologic domains. This is what we will attempt to explain in the next section.
8. An attempt to refute the homogeneity of emotion dysfunction in schizophrenia and
the quest for a possible treatment
At this point, we should have noted that despite extensive research for many years and
many promising hypotheses, we do not, yet, have a clear understanding of either the causes
of schizophrenia or how the causative factors lead to the clinical features. Previous researcli
has demonstrated abnormalities in most of the brain regions in schizophrenia. However,
these ultimately convincing findings have yielded disappointing conclusions in our quest to
understand schizophrenia as a disease. Hence, instead of advocating a “Gestalt” approach
(the whole equals the sum of its parts) to schizophrenia, researchers should investigate the
parts (symptomatology) then put them together to understand the whole (schizophrenia).
Thus, any attempts to understand it requires explanation of its various guises and
components. furthermore, although the general concept of negative symptoms has been of
considerable heuristic value and was successful in generating research findings leading to
six major theories of sub-typing (section 4 in the introduction), the time has corne for
abandoning its general construct and focus on its discrete components. This approach may
yield findings that have potential significance for an understanding of etiologic and
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developmental aspects of schizophrenia. Furthermore, from a neuropsychopharmacological
view, the ideal treatment should flot be a single drug with multireceptor blockade
(“one-size-fits-ali” polypharmacy) but should require several specific and targeted
treatrnent strategies that are titrated to match the variable expression of illness in
each patient.
To that end, we have decided to bring together clinical experience (Dr. Emmanuel Stip,
Psychiatrist) and functional magnetic resonance imaging (Dr. Mario Beauregard), to focus
on a specific and important symptom (flat affect) and to investigate potential treatment. It is
perhaps valuable at this point to state our central hypotheses, which we have formulated in
the following three studies (please note that, for theese studies, we have recruited 25
schizophrenia patients, divided into two groups: 14 with and 11 without flat affect. Out of
the 14 with flat affect, 12 were treated with quetiapine for 22 weeks and then rescanned):
1) Study I: Investigating the heterogeneity of hypofrontality in schizophrenia patients
with (FA+) and without (FA-) flat affect and the role of the prefrontal cortex in
emotional experience through interpretation of emotional stimuli. The central
hypothesis we focus on in this study is that while passively viewing pictures with
negative emotional content, which entails neural activation of the prefrontal cortex
(orbitofrontal, mesial prefrontal, and anterior cingulate cortices), schizophrenia patients
FA+ would show relative decreased activity in these brain areas. Conversely,
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schizophrenia patients without flat affect (FA-) would show significant activation of the
same areas. b that end, we have used a directed search targeting the prefrontal cortex.
2) Study II: Since current thinking about the mechanisrns of schizophrenia, based on
fMRI, postulates a disruption in distributed functional circuits rather than a single
abnormality in a single brain region such as prefrontal cortex, we have decided to go
one step beyond the heterogeneity of hypofrontality, to investigate whole brain cortical
and subcortical differential heamodynamic flow between schizophrenia FA+ and FA-.
The aim of this second fMRI study was to compare regional brain activity in FA+
subjects and FA- subjects during the viewing of emotionally negative pictures.
Experientially, we hypothesized that the viewing of the negative pictures would induce
a greater negative emotional state in the FA- group compared to the fA+ group.
Neurally, we predicted that, relative to the FA+ subjects, the FA- subjects would show
significantly greater BOLD signal increases in the brain regions normally associated
with emotion processing (from the visual cortex, midbrain, amygdala, to the prefrontal
cortex) during the viewing of such stimuli. To that end, we have used a whole brain
analysis (global search) targeting regions, according to the litterature, involved in
emotion processing.
3) Study III: Could quetiapine (an atypical antipsychotic) play a role in “normalizing”
brain processing ofnegative emotions in schizophrenia FA+? Based on the notions that
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(j) stimuli with strong affective content modulates neural information processing both at
the cortical and subcortical levels, (ii) quetiapine modulates the mesocortical pathway
(from the midbrain to the prefrontal cortex) (iii) this pathway is involved in emotion
recognition, experience and expression, we predicted that:
a) Pre-quetiapine: schizophrenia patients with flat affect would demonstrate an
enhanced response only in subcortical regions (based on findings from Study II).
b) Post-quetiapine: schizophrenia patients with flat affect would demonstrate
significant activity both within cortical and subcortical regions.
c) When using a conjunctional analysis (post-hoc) schizophrenia patients with flat
affect post-quetiapine would not significantly differ from schizophrenia patients
without flat affect: both groups would reveal subcortical and cortical activation.
We used this analysis to show commonalities between the two groups (since FA
process emotions sirnilar to normal controls (please refer to Study I and II).
In summary, the use of multiple criteria to define contrasting cohorts makes it difficult
to identify the source of cohort differences. Although there were some conflicting
observations, results about emotional deficits in schizophrenia remained unquestioned for
several years. Furtherrnore, to date, research bas focused on the recognition of ernotions in
schizophrenia, much less interest bas been shown in the subjective experience of emotions
in ‘sub-groups’ of schizophrenia patients (i.e., with flat affect versus without flat affect).
The study of subjective experiences and strategy choice (either to be implicated and process
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the emotional situation or choose avoidance) based on these experiences requires
introspection and self-reports. Such research strategies are more difficuit to implement and
are often considered unreliable, particularly in patients with schizophrenia. Hence, this is
what this study has attempted to overcome. The main goal of the present investigation was
to identify the neural substrate associated with the passive viewing (experience, feelings
and strategy choice) of negative pictures in schizophrenia patients with and without flat
affect, using fMRI.
The results supported our à priori hypotheses. We hypothesized à priori that flat affect
reflects failure of coordinated interaction between two streams (from subcortical to
cortical). The hypothesis we tested in this study was guided by a theoretical framework,
which proposes that emotions are part of a neural multisystem. The responses of this
multisystem are represented both in subcortical regulatory structures (for example,
brainstem, midbrain) and in the cerebral cortex (mesial prefrontal gyrus, orbitofrontal
cortex and anterior cingulated). Hence, we predicted differential activation between FA+
and FA- patients in these areas.
Negative socio-emotional resonance in schizoplirenia: a functional
magnetic resonance imaging hypothesis.
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Summary
The aim of the present study is to use neuroscience theories about brain function
(mirror-neurons MN) to draw inferences about the mechanisms supporting emotional
resonance in two different groups of schizophrenia patients (with flat affect fA+ n13 and
without flat affect FA- n=1 1). We hypothesize that FA+ will flot activate key brain areas
involved in emotional processing. Conversely, FA- will have a functional mirror system for
emotional resonance confinned by activation of the prefrontal cortex and behavioral resuits.
To test this hypothesis, we compared the 2 groups using blood oxygenation level dependent
(BOLD) functional magnetic resonance imaging (fMRI) displaying a passive visual task
(44 negative lAPS pictures and 44 neutral pictures). A random-effects analysis, for
schizophrenia patients FA-, revealed significant loci of activation in the lefi mesial
prefrontal (MPFC), right orbitofrontal (0fC) and lefi anterior cingulate cortices (ACC).
Correlational analyses carried out between self-report ratings of negative feelings and
BOLD signal changes revealed the existence of positive correlation in the LACC, LMPFC
and ROfC. ConverseÏy, FA+ did flot show significant activation in the prefrontal cortex.
We propose that negative emotional resonance induced by passively viewing negative
pictures may be a form of “mirroring” that grounds negative feelings via an experiential
mechanism. Hence, it could be argued that FA- were able to ‘feel’ emotions through this
resonance behavior. Conversely, we suggest that the dysfunction seen in the FA+ group is a
failure or distortion in the development of the MN system. This could be due to genetic or
other endogenous causes, which affected prefrontal cortex MN involved in emotional
resonance.
Key words: mirror-neurons, emotional resonance, schizophrenia, flat affect, functional
magnetic resonance imaging, prefrontal cortex.
37
INTRODUCTION
In the past decades, researchers have attempted to delineate the functionai elements
and associated brain regions important for socio-emotionai processing. In this paper, we
will be using neuroscience theories to address these questions, traditionally of interest to
psychologists and psychiatrists.
Mïrror fleurons: from primates to humans
When a monkey passively observes others perform specific gestures or actions,
premotor and motor cortical areas involved in the internai representation and actual
execution of those actions exhibit neuronal activation (1,2). This mechanism matches
observation, representation, and execution, facilitating internai motor rehearsai, imitation,
recognition of actions by others, their meanings and social learning (1-3). The functional
properties of these celis have led Rizzolatti, Gallese, and coileagues to coin the term
“mirror fleurons” (MN) (4). In other words, mirror-neurons are defined as neurons that
discharge both when the monkey makes a particular action and when it observes another
individual (monkey or human) making a similar action (5). With their latest study, Umilta
and coileagues (6) further our knowledge about the ftinction of “mirror neurons”
significantiy and provide now strong evidence for its capability to encode not only fully
perceived but even visually inferred action.
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On this theoretical grounds, it is conceivabie to propose that neurons of this type
becarne co-opted during evolution to serve the processing of internai representation and
reaction to socio-emotional enviromnental stimuli through a mirror neuronal system (2,7,8).
four unes of evidence strongly suggest that an actionlobservation matching system sirnilar
to that demonstrated in rnonkeys also exists in humans. The first refers to a study by fadiga
et al. (9), in which the authors stimulated the motor cortex of normal subjects (transcranial
magnetic stimulation) while they observed an experimenter grasping 3D-objects.
Jnterestingly, they found that the motor evoked potentials (MEP) significantly increased
during the conditions in which subjects observed movements. Moreover, The MEP pattem
reflected the pattem of muscle activity recorded when the subjects executed the observed
actions. This study provided for the first tirne evidence that hurnans have a mirror system
sirnilar to that in monkeys. Another more intriguing evidence is psychological studies using
mental chronometry tasks. These studies have shown that there is a remarkable parailelism
between motor imagery and motor execution (10,11,12). for example, vegetative responses
(such as increasing heart rate and biood pressure) associated with physical effort vary in the
same maimer during both motor imagery (presentation of a motor stimulus) and motor
performance (13). The third evidence, cornes from a study where the authors demonstrate
that, during speech listening, there is an increase of rnotor-evoked potentials recorded ftorn
the listeners’ tongue muscles when the presented words strongÏy involve, when pronounced,
tongue movernents (14). The fourth evidence was dernonstrated by (15) using functional
rnagnetic resonance imaging.
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The authors showed that when individuals observe an action, an internai replica of
that action is automatically generated in their premotor cortex. In the case of object-related
actions, a further object-related analysis is perforrned in the parietal lobe, as if the subjects
were indeed using those objects. Buccino and colleagues (15), hence, argued that these
resuits bring the previous concept of an action observationlexecution matching system
(mirror system) into a broader perspective: this system is flot restricted to the ventral
premotor cortex, but involves several somatotopically organized motor circuits. of
particular relevance to our study, in an emotional situation, humans exhibit nonconscious
mimicry ofothers’ facial expressions, postures and maimerisrns (the chameleon effect) (16).
In other words, since emotional states are closely linked to certain facial expressions,
observation of an emotional situation (e.g., murder) might result in a mirrored emotional
state. In this article we cail it emotional resonance, which is the ability to mentally
represent the emotional stimuli in ones environment. Such a process might help to explain
the phenomenon of emotional contagion, in which people automatically mirror the postures
and moods of others (17). 0f particular relevance, there is direct electromyographic
evidence that observers adopt facial muscle activity congruent with expressions witnessed
even when this process is not at an overt level (18). Thus, in humans as in nonhuman
primates, it seems that an internai replica of a perceived action is automatically generated,
represented as if the subjects were themselves performing that action.
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Socio-emotional impairment in schizophrenia
Imagine you are telling two persons a story about your child who witnessed a
murder two days ago. As the stoiy progresses, one person seems amused and displays an
inappropriate laughter making you and the other person, who displayed empathy,
uncomfortable. As a result, you terminate the interaction as quickly as possible. Most
people leam early in life to display socially appropriate responses, and that displaying an
inappropriate social response or no response, could lead a person to become socially
alienated. For example, schizophrenia patients with flat affect (FA+) have deficits in
processing emotions displayed by others, which likely relates to their poor social adaptation
and functioning (19,20,21). Descriptively, flat affect refers to an absent, constricted,
unvarying and sometimes unrelated or inappropriate affect. In this vein, patients exhibit an
expressionless face, unvarying, monotonous voice, they are socially withdrawn, lack
spontaneity and indifferent to the surrounding (19). Jnterestingly, in a recent preliminary
report done by our group, we demonstrated no significant difference between schizophrenia
patients without flat affect (FA-) and normal controls in processing emotions (22).
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Hypothesis : socïo-emotïonal resonance through a mirror system
The central hypothesis we focus on in this study is that while passively viewing
pictures with negative emotional content, requiring neural activation of the preftontal
cortex (orbitofrontal, mesial prefrontal and anterior cingulate cortices (OMACC)
(23,24,25,26,27,28), schizophrenia patients FA+ would show relative decreased activity in
these brain areas. Conversely, schizophrenia patients without flat affect (FA-) would show
significant activation of the same areas. On that account, we propose that the OMACC play
a role in emotional resonance between individuals. We suggest that these areas, of the
prefrontal cortex, have a similar role to the mirror neuron system demonstrated in primates
and humans. A possible role for the mesial prefrontal (MPFC), orbitofrontal (0fC), and
anterior cingulate cortices (ACC) in voluntary emotional self-regulation (26,27), social
learning (8) and in the internai representation of emotional expressions (7) was previously
investigated (for a complete review see 25). Therefore, we used functional magnetic
resonance imaging (fMRI) in schizophrenia patients FA+ and FA to detect relative changes
ofblood flow in these cortical areas.
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METHODS AND MATERIALS
Subjects
Fourteen DSM-W schizoplirenia patients with flat affect and eleven without flat affect
participated in the study. In the flat affect group the mean age was 27.57 ±8.90, range: 20-
46 and in the without flat affect 25.73 ±4.43, range 21-37. Ail subjects gave written
informed consent after a detailed explanation. The local scientific and ethics committees
approved the study.
Psychïatric assessment
Psychiatric assessments included the patient version of the Structured Clinical
Interview for DSM-W (SCD), and the Positive and Negative Symptoms Scale (PANSS)
(29) (flat affect symptom (fA+5.50 ±0.76; FA-=1.45 ±0.82, p=O.0001); emotional
withdrawal (FA+=5.00 ±1.04; FA-=1.73 ±0.90, p=O.000Y)). The Rating Scale for
Emotional Blunting (RSEB) (19) (FA+=19.86 ±1.70; fA-=6.00 ±1.41, p=O.0001). Criteria
for entry into the study were a diagnosis of DSM-W schizophrenia, no concomitant axis I
or axis II disorder, and no medical or neurological disease. $chizophrenia patients with flat
affect had a score higher then 17 and schizophrenia patients without flat affect had a score
lower then 10 on the RSEB. Patients were stabilized on antipsychotic medications: FA+
subjects received: Haloperidol (one subject) lOrng ± 0.0; zuclopentixol (two subjects)
lSOmg ± 0.0; risperidone (8 subjects) 3.3mg ± 1.4; olanzapine (four subjects) 21.2mg ±
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6.2. FA- received: Haloperidol (three subjects) 6.7mg ± 2.9; zuciopentixol (two subjects)
1 25rng ± 35.0; risperidone (4 subjects) 5.5mg ± 3.5; olanzapine (txvo subjects) 17.5mg ±
3.5; quetiapine (two subjects) 300mg ± 353.
Experimental setup
Blood oxygen level dependent (BOLD) signal changes were measured during two
experimental conditions, i.e., a Negative condition and a Neutral condition. Negative
emotions (disgust, fear, anger, surprise) were induced during firnctional magnetic resonance
imaging (fMRI) brain scalrning using negative scenes from 44 coiored visual pictures of
faces and recoilections of unhappy events (e.g., plane crash, snake, spider, shark, angry
face, sad face, mutilation, accident, burn victim, dead body, dying man, aimed gun, electric
chair). Another series of 44 neutral pictures (e.g., chess, tourist, rocks, boat, leaves, outlet,
towel, spoon, mug, basket, fan, iron, shoes, fork, umbreila, iamp, plate, chair) were also
presented. The order of presentation was: one block of negative pictures followed by one
block ofneutrai ones (each condition repeated 4 tirnes). Ail pictures were seiected from the
International Affective Picture System (lAPS) (30), to be sirnilar in compiexity and quality.
The two primary dimensions are one of affective valence ranging from pleasant to
unpieasant (negative: mean 2.66 ±1.58 versus neutral: mean 5.74 ±1.47), and one ofarousai
ranging from cairn to excited (negative: mean 6.11 ±2.14 versus neutral: mean 2.97 ±2.08).
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Both groups of schizophrenia patients (FA+, n =14; FA-, n =11) were instructed to react
normally to the 88 pictures seen during scanning (that is to allow themselves to become
emotional in response to these stimuli). The emotionally negative and neutral conditions
corresponded to one functional run, where each picture was presented for a period of 2.88
seconds. Each block lasted 31.6$sec. Blocks were separated by resting periods of 14.4s
during which subjects viewed a blank cyan screen. Overali, the whole functional run lasted
6.144 mm: (8 blocks: 4 negative and 4 neutral; 11 volumes per block; 5 volumes separating
each block; each picture was presented for 2.88s). These stimuli have been carefully
developed to ascertain how each negative/neutral slide makes an individual feel (i.e., the
conscious experience of emotion). To assess the subjective responses of the subjects to the
stimuli, immediately at the end of each run, they were asked to rate verbally on a subjective
rating scale ranging from O (absence of any negative emotional reaction) to $ (strongest
emotion ever feit in one’s lifetime) - the average intensity of negative emotions (felt during
the viewing of negative LAPS pictures. The exact instruction was: “please rate how you
actually feit while watching the pictures inside the fMRI machine”.
Image acquisition and analysis
Echoplanar images (EPI) were acquired on a 1.5 Tesla system (Magnetom Vision,
Siemens Electric, Erlangen, Germany). Twenty-eight slices (5 mm thick) were acquired
eveiy 2.65 s in an inclined axial plane, aligned with the AC-PC axis. These T2* weighted
functional images were acquired using an EPI pulse sequence (TE = 44 ms, Flip =
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90°,FOV = 215 mm, Matrix = 64 x 64). following functional scanning, high-resolution
data were acquired via a Tl-weighted three-dimensional volume acquisition obtained using
a gradient echo pulse sequence (TE = 44 ms, Flip = 12 FOV = 250 mm, Matrix = 256 x
256). Data were analyzed using Statistical Parametric Mapping software (SPM99,
Weilcome Department of Cognitive Neurology, London, UK). Images for ail subjects were
realigned to correct for artifacts due to small head movements. The gradient-recalled echo
planar sequence that we used is associated with large static magnetic field inhomogeneities
commonly found near air/tissue interfaces (31). These inhomogeneities can create artifacts
like signal loss and voxel shifts in the ventral frontal, medial temporal, and inferior
temporal regions (32). To correct for such artifacts, a mask vas applied to the suces of the
mean EPI image which presented signal loss. This procedure was implemented for every
subject. The images for ail subjects were then spatially normalized (voxel size: 3 mm x 3
mm x 3 mm) into an MRI stereotactic space (33) using this masked mean image. Images
were then convolved in space with a three-dimensional isotropic gaussian kemel (12 mm
FWHM) to improve the signal-to-noise ratio and to accommodate for residual variations in
functional neuroanatomy that usually persist between subjects afler spatial normalization.
For the statistical analysis, the time series of the images were convolved with the delayed
box-car function which approximates the activation pattems. Effects at each and every
voxel were estimated using the general linear model. Voxel values for the contrasts of
interest yielded a statistical parametric map of the t statistic (SPM t), subsequently
transformed to the unit normal distribution, ($PM Z).
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A multisubject analysis was performed by using a random-effects approach, which
takes into account intersubject variance permitting population-level inferences (34).
Statistical parametric maps were generated by using the general linear model within SPM
(35). First, the signal time course for each subject was modeled with a boxcar function
convolved with a hemodynamic response function and hi-pass filtering. Each of the
negative or neutral lAPS conditions was contrasted with each other and the baseline
condition, thereby creating one contrast image per subject for each condition. These images
were entered into a “one-sample t test” to investigate the significant activation during each
condition. Significant signal changes for each contrast were assessed using t statistics on a
voxel-by-voxel basis (34). The resulting areas of activation were characterized in terms of
their peak height and spatial extent. Second, for the group analysis, within-group t tests
were performed on subtractions of beta weights contrasting two conditions at each voxel.
Subtractions were negative emotional activation minus the neutral condition (each block
seperatly). Voxels showing significantly greater response were examined in the group
contrasts between patients with flat affect and patients without. Both “patients FA+ minus
patients FA-” and the opposite contrasts were performed.
An à priori search strategy was used, and a srnall volume correction was performed in
the brain regions of interest (ROI) defined à priori. The search volume corresponding to the
ROIs was defined à priori by tracing the neuroanatomic boundaries of these regions on the
MR reference image (Montreal Neurological Institute (MNI) template), using small volume
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correction (SVC) and box volume function in SPM99. For this à priori search, a
probability threshold for multiple comparison of a corrected P<O.05 was used. Only
clusters showing a spatial extent of at least five contiguous voxels were kept for image
analysis. In the negative condition, the à priori search strategy encompassed the mesial
frontal cortex, the orbitofrontal cortex, and the anterior cingulate cortex. These brain
regions have been found activated on a more or less consistent basis in previous functional
neuroimaging studies of emotions (as noted in the introduction).
RESULIS
Subjective ratings
Post-scan ratings (t-tests) of negative emotional feelings experienced during the scan
revealed a group effect on the mean subjective ratings of negative emotions felt during the
passive viewing ofthe negative pictures. On a scale of 0 to 8, the FA+ group averaged 1.00
± 1.52, range: 0-5 and the FA- 5.9 ±1.22, range: 3-7 (t=-$.71, df=23, p<O.000l).
JMRIData: Si,btractioi, Approach
In the present study we concentrate on frontal lobe (MPFC, OFC, ACC) activations
associated with emotion representation. Other activations will flot be dealt with here, as our
à priori hypothesis focused on potential chaiiges ofbrain activity in prefrontal areas.
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The “random-effects model (FA+ minus FA-) for negative minus neutral pictures did flot
reveal any significant locus of activation in the prefrontal cortex. Conversely, the FA
group showed significant loci of activation in the left ACC (BA 32) (coordinates of
maximum = (-3, 16, 37); z= 4.62; pO.OO2, conected; 6$ voxels); the right OFC (BA 47)
(coordinates of maximum = (45, 23, -6); z= 4.34; pO.OO5, corrected; 26 voxels); and the
lefi MPFC (BA 10) (coordinates of maximum = (-3, 56, 17); z= 3.56; pO.Ol, corrected; 14
voxels).
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figure 1
figure 1. Cortical anatomy of emotional resonance. Significant increases of BOLD
activation during passive viewing of the contrast negative minus neutral pictures. ta)
activation in the lefi ACC (BA 32) (coordinates of maximum = (-3, 16, 32); z= 4.62;
pO.OO2, corrected; 62 voxels); (b) the right OFC (BA 47) (coordinates of maximum = (45,
23, -6); z= 4.34; pO.OOS, corrected; 26 voxels) and (c) the lefi MPfC (BA 10) )
(coordinates of maximum = (-3, 56, 17); z= 3.56; pO.Ol, corrected; 14 voxels).
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IMRI Data: A Posteriori Correlational Analyses: Brain activation and self-report
ratings
Correlational analyses were conducted between self-report ratings and BOLD signal
increases found in the ROIs. These analyses revealed the existence of positive correlations
in the lefi ACC (coordinates of maximum = (-6, 30, 35); z= 3.81; pO.OOl, uncorrected; 21
voxels), the right 0fC (BA 47) (coordinates of maximum = (42, 23, -9); z= 3.66; pO.OOl,
uncorrected; 5 voxels), and the left MPfC (coordinates of maximum = (-9, 53, 8); z= 3.52;
pO.OO1 uncorrected, 5 voxels). These resuits confirm the robustness and validity of our
findings.
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DISCUSSION
The aim of the present study was to use information about brain function to draw
inferences about the mechanisms supporting emotional resonance in two different groups of
schizophrenia patients. In this sense, it represents one example of a growing trend towards
using neuroscience methods to address questions that traditionally have been of interest to
social and personality psychologists. What is the function of a mirror-system? One possible
function could be to intemally reproduce the same action, thus creating a resonance
behavior, which is at the basis of the understanding of actions made by others. Hence,
humans may use mirror-system for more complicated social interactions (e.g.,
understanding others’ emotions and intentions). In this article, we discussed this
hypothesis using two groups of schizophrenia patients with and without flat affect.
Noteworthy, in a previous study by our group (22), we did flot find a significant difference
between FA- patients and normal controls in processing emotions. The results of this study
support our hypothesis on the role of OMACC mirror-system for representing emotions
displayed in the pictures, thus making the FA- group feel them (as a result of the resonance
behavior). This interpretation is supported by four facts. First, loci of activation of these
areas were found only in the FA- group. Second, the positive correlation found between the
subjective rating score and these areas. Third, inactivation of the same areas in the
schizophrenia group FA+. Fourth, the latter group scored less on the subjective rating score
and we found.
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The above finding is very intriguing. Its interpretation, however, is flot
straightforward. In this study, we treated negative emotions as a single, unified entity.
Recent literature has clearly shown that different emotions seem related to different neural
systems. For example, disgust seems to activate preferentially the anterior insula (36),
whereas fear seems to activate preferentially the amygdala (37,25), and sadness seems to
activate the orbitofrontal cortex (22, 26, 27). We adopted this approach because our main
goal was to investigate the negative emotional resonance through a mirror-system in the
prefrontal cortex. Future studies may successfully employ further paradigms exploring the
differential neural correlates of each emotional mirror-system. furthermore, outstanding
questions remain. First, is minor-neuron activity innate or leamed? Second, do they have a
role in imitation and the theory of mmd? Third, how do minor-neurons relate to other
social information processing neurons in performing social cognitive functions (e.g.,
remembering a sad event)? It is perhaps valuable at this point to ask why the prefrontal
cortex? Both lesion and functional imaging studies in humans (38,25), as well as
neurophysiological studies in nonhuman primates (39), demonstrate the importance of the
prefrontal cortex in “representing” the emotional value of environmental stimuli. 0f
particular relevance to this study, Kawasaki and colleagues (40) investigated single-neuron
responses to emotional stimuli in an awake person with normal intellect. Using recording
from neurons within healthy tissue in ventral sites of the right prefrontal cortex, they found
short-latency (120-160 ms) responses selective for aversive visual stimuli (lAPS pictures:
same pictures shown in our study, see methods).
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Furthermore, the authors argued that regions of the mesial aspects of the frontal cortex
seem especially important in relating information about extemal sensory stimuli to
introceptive information that represents emotional significance.
Where dïd the ïdea of “emotional-resonance” corne from?
The resuits of this study were predicted on the basis of three models. The first is the
evidence found by. Fadiga and colleagues (9). Using transcranial magnetic stimulation
(TM$) experiments, the authors demonstrated that the human equivalent matching system
facilitates in the observer the same muscle groups as those utilized by the target. This
supports the idea that even when one is observing the action of another, one undergoes a
neural event that triggers actual movement in the observed agent. The point is that mirror
neurons activity is not mere theoretical inference. It creates in the observer a state that
matches that of the target. The second model is mirror neurons and the simulation theory of
mind-reading (for a review please refer to 2), which suggests that subjects use their own
mental mechanisms to calculate, attribute and predict both, the mental processes of others
and environmental stimuli. 0f relevance, the example used in this study: rating negative
emotions feit during the scanning session. Hence, according to the simulation theory, each
subject would have put himself in each of the pictures ‘shoes’ and imagined how he would
have felt in their place (41). Overail, the simulation theory depicts ‘mind-reading’ as
incorporating an attempt to replicate, mimic, or impersonate the mental life of the target
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agent (42). The third model is resonance behaviors and mirror neurons (for a complete
review see 5).
At the neurophysiological level, this model suggests that resonance behavior is
characterized by the occurrence, at the observation of environmental stimuli, of a neural
pattem, which, when internally generated, determines the making (feeling) of the observed
action. In this type of resonance behavior the observed action is, typically, flot repeated
(overtly), but for example feit. This model argues that this resonance behavior is at the
basis of the understanding of actions made by others. furthermore, clinical evidence for a
mirror system in humans is found in ‘imitation behavior’ (43). A group of patients with
prefrontal lesions compulsively imitate gestures or even complex actions performed by the
experimenter. This behavior is explained as an impairment of the inhibitory control
normally goveming motor plans. Hence, normal humans, when observing someone else
perform an action, generate a plan to do the same action, conversely, this plan is inhibited
so that it does not yield motor output. Such inhibition is impaired in the patient population
in question. In addition, in a recent review by Williams and colleagues (44), the authors
proposed that some dysfunction in the minor-neuron system might be implicated in the
generation of the constellation of clinical features which constitute the autistic syndrome,
especially, socioemotional functions.
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The most basic hypothesis for the dysfunction seen in the fA+ group would be that
there is a failure or distortion in the development of the mirror neuron system. This could
be due to genetic or other endogenous causes, to external conditions adverse to MN
functioning, or some interaction between these. Such factors might have affected prefrontal
cortex MN involved in emotional resonance. This in tum could explain the failure to
develop reciprocal social abilities including emotion recognition.
Why some schizophrenia patients have flat affect?
Emotional experience occurs through a number of steps: activation of the mechanism of
emotional recognition, comparing it to previous knowledge, representation of the emotion
and finally the decision of transmitting this emotional representation to key brain areas
involved in the experience emotion. Therefore, a process of emotion recognition and
representation resuits in this representation becoming a trigger for the mechanism deciding
upon the emotional experience. By requiring patients to passively view negative pictures,
we create a situation in which patients will either have to choose an active response (i.e., be
involved in the experience of negative emotions) or an avoidant response (deny/suppress
experiencing negative emotions). Persistent recurrence of unwanted, upsetting thoughts,
such as a history of childhood emotional invalidation (i.e., psychological abuse and parental
punishment, minimization, and distress in response to negative emotion) or abuse and adult
psychological distress could result in chronic emotional inhibition (45, 46, 47). Kraus et al.
(48) demonstrated that individuals who recollect a pervasive history of emotional
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invalidation in childhood are more likely to report the use of strategies designed to avoid or
inhibit the experience and expression of emotion as an aduit. furthermore, Eisenberg,
Cumberland and Spinard (49) reported that chronic emotional inhibition have long-term
negative consequences for the inhibitor, such as avoidant regulatory strategies, absent,
constricted, unvarying and sometimes unrelated or inappropriate affect and social
withdrawal.
Going one step further, we could suggest that emotional numbing or flat affect could
be the resuit of a long time (chronic) withholding of emotional expression. Based on our
findings, we don’t know if this emotional inhibition refers to conscious or subconscious
attempts to suppress emotional experience, a possibility that awaits further experimental
analyses. However, we do know that the emotional information was not transmitted from
the midbrain to the prefrontal cortex. The most direct interpretation of this finding is that
the schizophrenia patients FA+ “chose” the avoidant coping strategy: a response style in
which the emotional impact of negative emotions is denied. This seems to be a simple
observation, but it might reflect the operation of fundamentally different mechanisms. An
alternative explanation might be that FA+ are not inhibiting emotional experience, but
unable to mentally represent it in the first place. The appropriately developing child initially
recognize and represents his own emotions through parental and social interactions (45). If
this process is disturbed, then the mental representation and of his own and others’
emotions is also disturbed.
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Major theories of emotional development (50,51) suggest that young chiidren acquire
their emotional understanding from social interactions. Hence, they are highly vigilant to
the emotional states displayed by caregivers and oflen use such affect displays as a way to
cope with ambiguous or stressful situations (52). Such theories would also assert that if
parents, in particular, are emotionally unavailable during stressful situations due to
problems with emotion regulation, then chiidren may ultimately develop coping styles that
lead to avoidance of emotional experience.
Overali, our findings fit well with previously published imaging data on observation
of emotional stimuli that report activation of the prefrontal cortex (for a review, see 25).
We propose that negative emotional resonance induced by passively viewing negative
pictures may be a form of “mirroring” that grounds negative feelings via an experiential
mechanism providing a potential bridge between minds “standing in others mental shoes”.
If our proposal gains further empirical support, this may suggest important new avenues for
both cognitive and pharmacological remediative strategies especially tailored to the
prefrontal cortex pharmacology.
5$
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Abstract
The aim of this functional magnetic resonance imaging (fiviRT) study was to compare
regional brain activity in schizophrenia subjects with (FA+) and without (FA-) flat affect
during the viewing of emotionally negative pictures. Thirteen FA+ subjects and eleven FA
subjects were scanned while being presented with series of emotionally negative and
neutral pictures. ExperientiaÏly, the viewing of the negative pictures induced a negative
emotional state whose intensity was significantly greater in the FA- group than in the FA+
group. Neurally, the Negative minus Neutral contrast revealed, in the FA- group, significant
loci of activation in the midbrain, pons, anterior cingulate cortex, insula, ventrolateral
orbitofrontal cortex, anterior temporal pole, amygdala, medial prefrontal cortex, and
extrastriate visual cortex. In the FA+ group, this contrast produced significant loci of
activation in the rnidbrain, pons, anterior temporal pole, and extrastriate visual cortex.
When the brain activity measured in the FA+ group was subtracted from that measured in
the FA- group, only the lingual gyrus was significantly activated. Perhaps in FA+ subjects
an amygdaloid malfunction rendered the amygdala unable to correctly evaluate the
emotional meaning of the pictures presented, thus preventing effective connectivity Iinking
the amygdala to the brain regions implicated in the physiological and experiential
dimensions of emotion. Alternatively, a disturbance of effective connectivity in the neural
networks linking the midbrain and the medial prefrontal system was maybe responsible for
the quasi absence of emotional reaction in FA+ subjects, and the abnormal functioning of
the medial prefrontal cortex and anterior cingulate cortex in the FA+ group.
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1. Introduction
Although emotional blunting (also called “flat affect”) has aiways been considered a
core symptom of schizophrenia (Bleuler, 1911), it has been excluded from diagnostic
criteria because of its alleged unreliability until 1978 when Abrams and Taylor developed
the Rating Scale for Emotional Blunting (RSEB). These authors reviewed the literature for
clinical descriptions of emotional blunting, starting with Pinel (1801) and ending with
Kraepelin (1919). These descriptions included items such as lack of emotional depth, silly
laughing, shallow emotional response, emotional dullness, absence of feelings and
indifference towards relatives and friends. Abrams and Taylor (1978) organized these
descriptions under three headings relating to affect, thought content and behavior.
Interpersonal behavioral studies using naturalistic behavioral measures of social
functioning have shown that schizophrenia is associated with reduced facial expression
during social interaction (Kause et al., 1989), diminished expressiveness in response to
emotional films (Berenbaum and Oltmanns, 1992), and difficulties in everyday social
experiences resulting from poor conversational skills and impairments in emotional
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nonverbal expressiveness (i.e., body gestures, facial expression) (Alpert et al., 2000, 2002;
Kohier et al., 2000; Mattes et al., 1995; Sweet et al., 1998). furthermore, negative
symptoms in schizophrenia are associated with difficulties in everyday social experiences,
including fewer social contacts, poor work quality, lower scores on global assessments of
functioning, and less ability to meet individual needs (Pogue-Geile et al., 1985; Breier et
al., 1991). In line with this, electromyography (EMG) studies (Iwase et al., 1999; Kring et
al., 1999; Sison et al., 1996) have shown that flatness of affect was associated, in
schizophrenia, with less zygomatic (cheek) activity and reduced ability to express happy
facial expressions, such as smiling. Moreover, Bryson and colleagues (1998) reported that
patients with negative symptoms are especially subject to difficulties in correctly
identifying and expressing the emotional content of both faces and scenes. In another study,
Voiz and collaborators (2003) investigated the temporal course of startie reflex modulation
to emotional pictures in schizophrenia subjects and normal controls. Participants viewed
pleasant, neutral and unpleasant pictures, which were presented for 6 s and acoustic startle
probes were delivered at five different times aller picture onset. Replicating previous
findings schizophrenia subj ects showed the same emotional modulation of the startie reflex
as healthy controls when probes were presented later during the picture-viewing period
(3800 ms). For the early probe times (300 ms and 800 ms), emotionally-laden pictures
proved to be the effective pre-pulse stimuli resulting in a clear pre-pulse inhibition (PP1)
effect in both groups. In contrast to previous findings, the PPI of startle response was flot
stronger during processing of emotional stimuli relative to neutral stimuli.
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For control subjects, blink reflexes were larger for unpleasant pictures compared with
neutral and pleasant pictures, representing an early activation of the motivational system.
Voiz and colleagues (2003) concluded that if it takes longer for the emotional system to
encode the relevant information, it takes longer for the behavioral adjustment to occur in
response to this encoding process. Since facial expression changes very quickly in response
to different emotional stimuli, a deficit in encoding the emotional content of a cue might
disturb an appropriate facial response to emotional stimuli.
There is mounting evidence that brain regions implicated in emotion
processing/experience may be dysfunctional in individuals with schizophrenia. Using
positron emission tomography (PET), Potkin and colleagues (2002) demonstrated lower
glucose metabolic rate in the ftisiform area in schizophrenia subjects with predominantly
negative symptoms. Crespo-facorro et al., (2001) demonstrated with PET that, relative to
healthy volunteers, schizophrenia failed to activate limbic/paralimbic regions during the
experience of unpÏeasant odors. Along the same unes, Paradiso and colleagues (2003)
rneasured regional cerebral blood flow (rCBF) during performance of a task that required
schizophrenia subjects and healthy voÏunteers to identify the emotional valence of visual
images. When schizophrenia subjects consciously evaluated the unpleasant images, they
did not activate the amygdala, unlike the healthy volunteers. Likewise, schizophrenia
patients showed no activation in prefrontal cortical areas normally involved in the
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evaluation of the emotional significance of visual stimuli. Paradiso and co-workers (2003)
concluded that this failure of the fleurai systems implicated in emotional attribution is
consistent with pervading problems in experiencing emotions by schizophrenia subjects. In
another PET study, Schneider et al., (1998) found that unlike normal controls,
schizophrenia did not show amygdala activation during sadness, despite matched ratings to
normal controls indicating a comparable negative affect. More recently, Gur and colleagues
(2002) showed in the left hemisphere a significantly greater blood-oxygen-level-dependent
(BOLD) amygdalar signal increase in control subjects than in schizophrenia subjects during
emotionai valence discrimination tasks. Lastly, Takahashi et al. (2004) used functional
magnetic resonance imaging (fMRI) to investigate the neurai basis of impaired emotional
processing in schizophrenia. Normal control and schizophrenia subjects were instructed to
indicate how each of the presented pictures made them feel. In normal controls, BOLD
signal increases were noted in the thalamus, basal ganglia, midbrain, hippocampal
formation, amygdala, medial prefrontal cortex (MPfC), visual cortex and the cerebellum
while viewing unpleasant pictures. In schizophrenia subjects, less activation was found in
these brain regions.
Worth mentioning, in an elegant study by Stark and colleagues (2004), subjective and
haemodynamic responses towards negative lAPS pictures (Lang et al., 1988) were
investigated using fiviRI. Within an interval of one week, 24 male subjects were scanned
71
twice in order to analyze possible response changes to repeated picture presentation (the
same pictures were presented). Interestingly, during the retest the affective ratings hardly
changed. However, most of the previously observed brain activations disappeared, with the
exception of the temporo-occipital activation. The stability of the visual cortex activation
over time suggests that the visual cortex is a very important component of the processing of
emotional stimuli visually presented.
Explanatory models of flat affect have proposed various etiologies, invoking
psychodynamic processes such as repression (Arieti, 1955) or emphasizing the role of
impaired social relations and social rejection (Pao, 1979). More recently, it has been
proposed that this negative symptom reflects a dysfunction in the right hemisphere (Mayer
et al., 1985). This stance is based on clinical neuropsychological evidence obtained in
individuals with cortical lesions located in the right hemisphere (Dolan, 1999; Critchley et
al., 2001). These individuals show inappropriate emotional responses that are strikingly
similar to those seen in schizophrenia with flat affect. It lias also been postulated that
emotional disturbances in schizophrenia resuits from a dysfunction of the medial preftontal
and anterior cingulate cortices (Weinberger, 1987; Mega et al 2001; Gur et al 2002).
However, these studies did not differentiate between schizoplirenia subjects with and
without flat affect. Various fines of evidence indicate that these prefrontal cortical regions,
which are heavily connected with limbic structures (e.g., hypothalamus and amygdala),
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play a pivotai role in emotion processing (Beauregard et al., 2004). 0f particuiar note,
these prefrontai areas have been consistently seen activated during the induction of
transient emotionai states in healthy individuais (for a review see Phan et al., 2002).
The aim of the current fMRI study was to compare regionai brain activity in
schizophrenia subjects with (FA+) and without (FA-) flat affect during the viewing of
emotionally negative pictures. Experientially, we hypothesized that the viewing of the
negative pictures wouid induce a greater negative emotionai state in the FA- group
compared to the FA+ group. Neuraiiy, we predicted that, relative to the FA+ subjects, the
FA- subjects wouid show significantiy greater BOLD signal increases in the brain regions
normally associated with emotion processing (midbrain, amygdaia, MPFC, etc.) during the
viewing ofsuch stimuii.
2. Methods
2.1. Subjects
Thirteen fA+ subjects and eleven FA- subjects participated in the study. In the FA+
group, the mean age was 27.57 ±8.90 years (range: 20-46) whereas in the FA- group, the
mean age was 25.73 ±4.43 years (range 2 1-37). In the FA+ group, the age of onset of
schizophrenia was 22.07 ±4.5 years while in the FA- group, this age was 21.27 ±2.72 years.
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The level of education was comparable in both groups of subjects (FA+ group: 10.50 ±3.65
years; FA- group: 10.36 ±2.58 years) (p=O.92). Ail subjects gave written informed consent
afier a detailed explanation. The local scientific and ethics committees (Hôpital Louis
Hippolyte Lafontaine and Centre hospitalier de l’Université de Montréal, Hôpital Notre-
Dame) approved the study.
2.2. Psychiatric assessments
Subjects were investigated using the patient version ofthe Structured Clinical Interview for
DSM-W (1994), the Positive and Negative Symptoms Scale (PANSS) (Kay et al., 1986),
the Rating Scale for Emotional Blunting (RSEB) (Abrams and Taylor, 1978) and the
Calgary Depression Rating Scale (CDS) (Addington et al., 1990) (Table 1). Criteria for
entry into the study were a diagnosis of schizophrenia (based on the DSM-W), no
concomitant axis I or axis II disorder, and no medical or neurological disease. On the
RSEB, FA- subjects had a score higher than 17 and FA+ subjects had a score lower than
10. Subjects were stabilized with various types of antipsychotic medications. Some of the
subjects received two antipsychotic drugs. Thus, in the FA+ group, subjects received
Haloperidol (one subject, 10 mg ± 0.0), Zuclopentixol (two subjects, 150 mg ± 0.0),
Risperidone (8 subjects, 3.3 mg ± 1.4), Olanzapine (four subjects, 21.2 mg ± 6.2). In the
FA- group, subjects received Haloperidol (three subjects, 6.7 mg ± 2.9), Zuclopentixol (two
subjects, 125 mg ± 35.0), Risperidone (4 subjects, 5.5 mg ± 3.5), Olanzapine (two subjects,
17.5 mg ± 3.5), andlor Quetiapine (two subjects, 300 mg ± 353). Using SPSS we have
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conducted a two-tailed independent sample t-test and found no significant difference (t
1.74; df= 23; p0.17) between the two groups in dose equivalent estimation to 100 mg/day
ofchlorpromazine (Woods, 2003).
RSEB
PANSS: Blunted affect
PANS S: Emotional withdrawal
PANSS: positive symptoms
PANSS: negative symptoms
PANSS :general psychopathology
PANSS: total
CDRS
FA+
19.86 ±1.70
5.50 ±0.76
5.00 ±1.04
3.09 ±1.38
4.48 ±1.04
3.06 ±1.24
3.40 ±1.23
6.7 ±4.53
Mean score
fA-
6.00 ±1.41
1.45 ±0.82
1.73 ±0.90
3.23 ±1.3 1
2.05 ±0.95
2.53 ±1.08
2.59 ±1.10
4.1 ±3.71
0.0001
0.0001
0.0001
0.56
0.02
0.33
0.31
0.12
Table 1. CDRS: Calgary Depression Rating Scale; PANSS: Positive
Symptoms Scale; RSEB: Rating Scale for Emotional Blunting.
and Negative
Table 1. Resuits of psychïatrîc assessment tests
Mean score and SD and SD p value
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2.3. Behavioral Procedures
BOLD signal changes were measured during two experimental conditions, i.e., a
Negative condition and a Neutrat condition. During the Negative condition, a series of 44
emotionally-laden negative pictures (e.g., plane crash, snake, spider, shark, angry face, sad
face, mutilation, accident, bum victim, dead body, dying man, aimed gun, electric chair,
etc.) were presented to the subjects whereas in the Neutral condition, subjects saw a series
of 44 emotionally neutral pictures (e.g., tourist, rocks, boat, leaves, outiet, towel, spoon,
mug, basket, fan, iron, shoes, fork, umbrella, lamp, plate, chair, etc.). The two categories of
pictures were selected from the International Affective Picture System (lAPS, Lang et al
1988). They were matched as much as possible in terms of visual complexity. The mean
valence was 2.66 ± 1.58 for the negative pictures and 5.74 ± 1.47 for the neutral pictures.
The mean arousal level was 6.11 ± 2.14 for the negative pictures and 2.97 ± 2.08 for the
neutral pictures. These mean valence and arousal scores are based on the valence and
arousal ratings from Lang’s normative groups. During the functional scan, four blocks of
negative pictures and four blocks of neutral pictures were presented to the subjects in an
alternating manner (negative, neutral, negative, neutral, negative, neutral, negative,
neutral). Each picture was presented for a period of 2.88 s and each block — which lasted
31.68 sec - comprised 11 pictures. Blocks were separated by resting periods of 14.4 sec,
during which subjects viewed a blank cyan screen. Subjects were instrncted to look
carefully at each of the 88 pictures presented to them during the run. To assess the
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subjective responses of the subjects to the stimuli, immediately at the end of the run,
subjects were asked to rate verbally on a subjective rating scale ranging from 0 (absence of
any emotional reaction) to $ (strongest emotional reaction ever feit in one’s lifetime) the
intensity of emotional reaction felt during the viewing of the negative pictures.
2.4. Image acquisition and Analysis
Echoplanar images (EPI) were acquired on a 1.5 Tesla system (Magnetom Vision,
Siemens Electric, Erlangen, Germany). Twenty-eight suces (5 mm thick) were acquired
every 2.65 s in an inclined axial plane, aligned with the AC-PC axis. These T2* weighted
functional images were acquired using an EPI pulse sequence (Echo-space time = 0.8 ms,
TE = 44 ms, Flip = 90°, FOV = 215 mm, Matrix = 64 x 64, Voxel size = 3.36 mm X 3.36
mm X 5 mm). Following functional scalming, high-resolution data were acquired via a
Tl-weighted three-dimensional volume acquisition obtained using a gradient echo pulse
sequence (TE = 44 ms, Flip = 12° FOV = 250 mm, Matrix = 256 x 256, Voxel size = 0.94
mm3).
Data were analyzed using Statistical Parametric Mapping software (SPM99,
Wellcome Department of Cognitive Neurology, London, UX). Images for all subjects were
realigned to correct for artifacts due to small head movements. The gradient-recalled echo
planar sequence that we used is associated with large static magnetic field inhomogeneities
commonly found near air/tissue interfaces (Cordes et al., 2000). These inhomogeneities can
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create artifacts like signal loss and voxel shifis in the ventral frontal, media! temporal, and
inferior temporal regions (Song et al., 2001). To correct for such artifacts, a mask was
applied to the slices of the mean EPI image, which presented signal loss. This procedure
was implemented for every subject. The images for ail subjects were then spatially
normaiized into an MRI stereotactic space (Taiairach and Toumoux, 1988) using this
masked mean image. Images were then convolved in space with a three-dimensional
isotropic gaussian kemel (12 mm FWHM) to improve the signal-to-noise ratio and to
accommodate for residual variations in functional neuroanatomy that usually persist
between subjects afler spatial normalization.
For the statistical analysis, the time series of the images were convolved with the
delayed box-car function which approximates the activation pattems. Effects at each and
every voxel were estimated using the general iinear mode!. Voxel values for the contrasts
of interest yielded a statistical parametric map of the t statistic ($PM t), subsequently
transformed to the unit normai distribution, (SPM Z).
A “fixed-effects model” was irnplemented to contrast the brain activity associated
with the viewing of the negative pictures and that associated with the viewing of the
emotionaliy neutral pictures (Negative minus Neutral). This “fixed-effects mode!”
produced individual contrast images, which were used as raw data for the implementation
of a “random-effects model”. This procedure, which estimates the error variance for each
7$
condition across the subjects, allows one to make inferences on the population which
participants are deemed representative (Friston and Frackowiack, 1997). Contrast images
were obtained from single-subject analysis and were entered into the group analysis. A one
sample t test was applied to determine group activation for the Negative minus Neutral
contrast. Significant clusters of activation were determined using the conjoint expected
probability distribution of the height and extent of z scores with the height and extent
threshold. Only clusters showing a spatial extent of at least five contiguous voxels were
kept for image analysis. In addition, we tested for relative differences in the pattem of
neural activation by subtracting the Negative minus Neutral contrast of the FA+ group from
that of the FA- group and vice versa. Between-group comparisons were perforrned with a
two-sample t test. Coordinates of activation were converted from MNI coordinates to
Talairach and Tourrtbux (1988) coordinates using the mni2tal algorithm (M. Brett,
Cambridge, MA). Contrast images were overlaid onto a group mean anatomy image
provided by SPM for viewing.
An à priori search strategy was used, and a small volume correction was performed in
the brain regions of interest (ROI) defined à priori. The search volume corresponding to the
ROIs was defined à priori, using small volume correction (SVC) and box volume function
in $PM99, and based on the neuroanatomic boundaries of these regions noted in the MR
reference image (Montreal Neurological Institute (MNI) template) and the Talairach and
Tournoux (1988) atlas. For this à priori search, a probability threshold for multiple
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comparison of a corrected P<0.05 was used. Only clusters showing a spatial extent of at
least five contiguous voxels were kept for image analysis. The à priori search strategy
encompassed the orbitofrontal cortex (OFC, Brodmann area (BA)47; box-center situated at
30,28,-l6mm bilaterally; box-volume=44,25,16; and, BA 11; box-center situated at
25,42.5,-20 mm bilaterally; box-volume=44,45,16), the anterior cingulate cortex (ACC
BA32; box-center situated at 4.5,22.5,29mm bilaterally; box-volume=13,40,53; and, BA
24; box-center situated at 4,9.5,20.5 mm bilaterally; box-volurne=2,51,49), the medial
prefrontal cortex (MPFC BA1O; box-center situated at 2.5,50,22mm bilaterally; box
volume=5,10,32; and, BA 9; box-center situated at 2.5,42.5,25.5 mm bilaterally; box
volume=5,5,19), the anterior temporal pole (ATP BA21; box-center situated at 56,-23.5,-
2mm bilaterally; box-volume=$,10,19; and, ATP BA3$; box-center situated at 40,10,-
22mm bilaterally; box-volume=20,12,34), the insula (box-center situated at 39,-2,-6mm
bilaterally; box-volume=4,32,2), the amygdala (box-center situated at 21,-2,-l4mm
bilaterally; box-volume= 8,10,11), the pons (box-center situated at 0,-22.5,-33.Smm; box
volume=32,25,29), and the midbrain (box-center situated at 6.5,8,-6.5mm bilaterally; box
volume=10,25,12). These brain regions have been found activated on a more or less
consistent basis in previous functional neuroimaging studies of aversive emotional states
(for a complete review please refer to Phan et al., 2002). In addition to our à priori ROIs,
we have also investigated differential activity in the visual cortex between the two groups
because ofits involvement in emotional perception (Lang et al., 1998; Stark et al., 2004).
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3. Resuits
3.1. Self-Report Data
Experientially, the viewing of the negative pictures induced a negative emotional state
whose intensity was significantly greater in the FA- group (5.9 ± 1.22, range: 3-7) than in
the FA+ group (1.00 ± 1.52, range: 0-5) (t = -8.71, df= 23, p<O.000l).
3.2. JMRI Data: Sttbtractioit Approach (Negative minus Neutrat coittrast,)
FA- group. The Negative minus Neutral contrast revealed significant loci of activation in
the midbrain, bilaterally, as well as in the right pons, lefi ACC (BA 32), lefi insula, lefi
OFC (BA 47), left ATP (BA 3$), left amygdala, and right MPFC; BA 10). Other loci of
activation were found in the left lingual gyrus (LG, BA 17/18), left superior occipital gyrus
(GOS, BA 19), right cuneus, right inferior temporal gyms (GTI, BA 37), and lefi fusiform
gyrus (FG, BA 37) (Table 2 and Figure 1).
Table 2. Stereotaxic coordinates are derived from the human atlas of Talairach and
Toumoux (198$) and refer to medial - lateral position (x) relative to medline (positive
right), anterior - posterior position (y) relative to the anterior commissure (positive
anterior), and superior
— inferior position (z) relative to the commissural une (positive
superior). Designation of Brodmaim areas for cortical areas are also based on this atlas.
ACC: anterior cingulate cortex, ATP: anterior temporal pole, GOS: superior occipital
gyrus, GTI: inferior temporal gyrus, LG: lingual gyrus, MPFC: medial prefrontal cortex,
OFC: orbitofrontal cortex. L, lefi; R, right.
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Table 2. Regionat brain activity in FA- subjects (Negative minus Neutral)
Talairach Coordinates (mm)
Brain region Brodmann
Area X Z Number Z Corrected
of Statistic p value
voxels
LLG 17/18 -12 -88 -8 48 5.44 0.001
L GOS 19 -24 -72 17 12 5.23 0.004
Rcuneus 15 -87 10 10 5.07 0.01
R GTI 37 47 -50 -15 9 4.95 0.01
LACC 32 -8 16 37 22 4.13 0.01
Llnsula -36 8 -13 12 4.11 0.01
LATP 38 -45 8 -23 13 4.04 0.01
LOfC 47 -39 19 -19 12 3.49 0.01
RMidbrain 12 -24 -15 32 4.02 0.01
L Amygdala -25 -7 -11 9 3.72 0.003
RMPFC 10 3 56 19 7 3.57 0.01
LMidbrain -12 -26 -9 32 3.17 0.01
Rpons 9 -23 -29 6 3.17 0.01
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Figure 1. Statistical activation maps in the FA- group for the Negative minus Neutral
contrast: (a) left LG (BA 17/18; z= 5.44, pO.OOl corrected), (b) lefi GOS (BA 19; z= 5.23,
pO.OO4 corrected), (c) right cuneus (z= 5.07, p0.Ol corrected), (d) right GlI (BA 37; z
4.95, p0.Ol corrected), (e) lefi ACC (BA 32; z= 4.13, p0.01 corrected), (f) left insula
(z=4. 11, pO.Ol corrected), (g) lefi ATP (BA 21; z=4.04, pO.Ol corrected), (h) left OFC
(BA 47; z3.49, p0.01 corrected), (j) right midbrain (z4.02, pO.Ol corrected), (j) left
Figure 1
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amygdala (z=3.72, p0.OO3 corrected), (k) right MPfC (BA 10; z=3.57, pO.Ol corrected),
(1) lefi midbrain (z=3.17, pO.Ol corrected), and (m) right pons (z=3. 17, pO.Ol corrected).
ACC: anterior cingulate cortex, ATP: anterior temporal pole, GOS: superior occipital
gyrus, GTI: inferior temporal gus, LG: lingual gyrus, MPFC: medial prefrontal cortex,
OFC: orbitofrontal cortex.
FA+ group. Significant loci of activation were noted in the midbrain, bilaterally, right
pons, right ATP (BA 21), right middle occipital gyrus (GOM, BA 19), and lefi LG (BA 19)
(Table 3 and Figure 2).
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Figure 2. Statistical activation maps in the FA+ group for the Negative minus Neutral
contrast: (a) right GOM (BA 19; z= 5.84, pO.OOl corrected), (b) lefi LG (BA 19; z= 5.21,
p<O.005 corrected), (e) right midbrain (z4.03, pO.OO3 corrected). (d) lefi midbrain
(z3.67, pO.Ol corrected), (e) right pons (z3.61, pO.O3 corrected), and (f) right ATP
(BA 21; z=3.22, pO.O3 corrected). ATP: anterior temporal pole, GOM: middle occipital
gyrus, LG: lingual gyms.
Figure 2
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Table 3. Regional brain activity in fA+ subj ects (Negative minus Neutral)
Talairach Coordinates (mm)
Brain region Brodmaim
Area X Z Number Z Corrected
of Statistic p value
voxels
RGOM 19 45 -73 -4 16 5.84 0.001
LLG 19 -18 -$2 -6 10 5.21 0.005
Right midbrain 18 -21 -9 33 4.03 0.003
Left midbrain -1$ -24 -4 10 3.67 0.01
Rightpons 12 -33 -26 19 3.61 0.03
RATP 21 42 -4 -28 12 3.22 0.03
Table 3. As in Table 2. ATP: anterior temporal pole, GOM: middle occipital gyrus, LG:
lingual gyrus. L, lefi; R, right.
FA- group minus FA+ group. Significant loci of activation were detected in the lefi ACC
(BA 32), right OFC (BA 47), left ATP (BA 21), left MPFC (BA 10), and lefi FG (BA 36)
(Table 4 and Figure 3).
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FA+ group minus FA- group. A significant locus of activation was detected in the lefi LG
(BA 19) (Table 4 and Figure 3).
87
Table 4. FA- group minus FA+ group and FA+ group minus FA- group (Negative minus Neutral)
Talairach Coordinates (mm)
Brain region
Brodmann X Z Number Z Corrected p value
area ofvoxels Statistic
FA- minus FA+
LFG 36 -32 -7 -22 95 4.63 0.007
L ACC 32 -3 16 38 68 4.62 0.02
R OfC 47 45 23 -6 26 4.34 0.05
LATP 21 -53 -6 -12 17 4.18 0.01
LMPFC 10 -26 55 1 12 3.94 0.01
Schizophrenia patients FA+ minus FA-, contrast negative minus neutral
LLG 19 -12 -73 -6 19 2.92 0.009
Table 4. As in Table 2. ACC: anterior cingulate cortex, ATP: anterior temporal pole, FG:
fusiform gyrus, LG: lingual gyrus, OFC: orbitofrontal cortex. L, lefi; R, right.
8$
Figure 3
Figure 3. Statistical activation maps produced by the FA- group minus FA+ group contrast
and the FA+ group minus FA- group contrast. FA- group minus FA+ group: ta) lefi
FG(BA 36) (coordinates of maximum (36, -32, -7); z= 4.63; pO.OO7, corrected; 95
voxels)), (b) lefi ACC (BA 32) (coordinates of maximum = (-3, 16, 38); z 4.62; pO.OO2,
corrected; 6$ voxels); (c) the right OFC (BA 47) (coordinates of maximum = (45, 23, -6);
z= 4.34; p<O.00S, corrected; 26 voxels); (d) the lefi ATP (BA 21) (coordinates of maximum
= (-53, -6, -12); z= 4.1$; pO.Ol, corrected; 17 voxels), and (e) the lefi MPfC (BA 10)
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(coordinates of maximum = (-26, 55, 1); z= 3.94; pO.O1, corrected; 12 voxels). FA+ group
minus FA- group: ta) left LG (BA 19) (coordinates of maximum = (-12, -73, -6); z= 2.92;
pO.OO9, corrected; 19 voxels). ACC: anterior cingulate cortex, ATP: anterior temporal
pole, FG: fusiform gyrus, LG: lingual gyrus, MPFC: medial prefrontal cortex, OFC:
orbitofrontal cortex.
3.3. fMRI Data: A Posteriori Correlational Analyses
Using the effect size - which represents the percent signal change of the BOLD response -
at the regional maxima uncovered in the between-group comparisons, we analyzed whether
the BOLD signal changes were correlated with the self-report rating scores using the simple
regression function in SPM99. These analyses revealed, in the FA- group, the existence of a
positive correlation between scores associated to viewing the negative pictures and
magnitude of activation in the left ACC (BA 32; coordinates of maximum = (-6, 30, 35); z=
3.81; p<O.00l, uncorrected; 21 voxels).
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4. Discussion
The present study was undertaken to compare regional brain activity in schizophrenia
with (FA+) and without (FA-) flat affect during the viewing of emotionally negative
pictures. hi keeping with our hypotheses, experientially the viewing ofthe negative pictures
induced a greater negative emotional state in the FA- group compared to the FA+ group.
Neurally, relative to FA+ subjects, FA- subjects showed significantly greater BOLD signal
increases in limbic/paralimbic brain regions during the viewing ofthe negative pictures.
The loci of activation noted, in both groups of subjects, in the various subdivisions of
the visual cortex are consistent with the role of this cortical region in the early visual
processing of emotional stimuli (Kee et al., 1998; Lang et al., 1998; Stark et al., 2004).
Adolphs (2002) proposed that presentation of an affectively laden stimulus triggers an
initial feed-forward information processing along occipital and temporal neocortices which
leads to a coarse categorization of affect within the first 100 ms. Likewise, Streit and
colleagues (1999) demonstrated that in healthy males the neural processes related to the
evaluation of facial expressions of emotions start at about 180 ms afier stimulus onset in
occipitotemporal brain regions spreading rapidly along the ventral visual pathway and
limbic structures to the inferior frontal areas. 0f particular relevance to our study, Bradley
and colleagues (2003) found, using fiviRI, that functional activation in the occipital cortex
was more extensive when normal participants view pictures strongly related to primary
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motive states (i.e., victims of violent death, viewer-directed threat, and erotica). This
functional activity was greater than that observed for less intense emotional (i.e., happy
famihes or angiy faces) or neutral images (i.e., household objects, neutral faces). Both the
extent and strength of functional activity were related to the judged affective arousal of the
different picture contents.
In the macaque, the extrastriate cortical visual areas project to the ipsilateral
dorsolateral region of the pontine nuclei (Glickstein et al., 1990). In squirrel monkeys
(Tigges et al., 1982), the extrastriate visual cortex sends projections to the pontine reticular
formation and the midbrain reticular formation. Some evidence suggests that the midbrain
and pons are involved in the mediation of autonomic responses such as skin conductance
responses (Sequeira et al., 1995) and body temperature changes (Nagashima et al., 2000).
The midbrain has been found activated in several functional neuroimaging studies of
diverse emotional states (e.g., disgust, sadness, anger, fear, anxiety) (Damasio et al., 2000;
Fredrikson et al., 1995; Lane et al., 1997a; Lévesque et al., 2003; Rauch et al., 1997). Given
that autonomic responses often accompany the autonomie experience of primary emotions
(Damasio et al., 2000), the bilateral midbrain activation noted here may be related to the
autonomie responses associated with the perceptual processing ofthe negative pictures.
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The ventrolaterai part of the 0fC (BA 47) has been found activated during external
andlor internai induction of negative emotional states (e.g., sadness, anxiety, anger)
(Beauregard et al., 1998; Damasio et al., 2000; Dougherty et al., 1999; Pardo et al., 1993;
Fredrikson et al., 1995; George et al., 1995; Kimbrell et ai., 1999; Lévesque et al., 2003;
Pelletier et ai., 2003). Tri view of the sensory inputs (olfactory, gustatory, visceral afferent,
somatic sensory, and visual) as well as the limbic inputs that this cortical region receives
from the amygdaia, entorhinai and perirhinal cortex, and subiculum (Price, 1999), it
appears conceivable that the activation ofBA 47 in FA- subjects during the viewing ofthe
negative pictures was related to the integration of viscerosensoly information with
information signaling changes in the subjects’ emotional state.
The positive correiation found in FA- subjects between average ratings of negative
emotion and BOLD signal increases in the rostral portion of the ACC is in une with the
positive correlation previously reported in healthy subjects between the magnitude of sad
feelings (externally induced by sad film excerpts) and that of BOLD signal increases in the
same part of the ACC (Lévesque et aI., 2003). This finding supports the view that the
rostral subdivision of the ACC plays a pivotai role in the interoceptive and exteroceptive
detection ofemotional signais (Lane et al., 1997b).
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The MPFC has been reported to be activated in several previous functional
neuroimaging studies of negative ernotional states (e.g., sadness, disgust) (Beauregard et
al., 199$; Damasio et al., 2000; George et al., 1995; Lane et al., 1997a; Reiman et al.,
1997). This prefrontal cortical region receives sensoiy infonnation from the body and the
external environment via the orbitofrontal cortex and is heavily interconnected with limbic
structures, such as the amygdala, hypothalamus, midbrain periaqueductal gray region, arid
brainstem autonomic nuclei (Barbas, 1993; Carmichael and Price, 1995). It is noteworthy
that a region of the MPFC close to that identified in this study lias previously been
postulated to be implicated in metacognitive representation of one’s own emotional state
(Lane. 2000; Reiman et al., 1997). In keeping with this, studies ofindividuals with damage
to the MPFC suggest that this cortical area is involved in the conscious monitoring of the
individual’s emotional state (Damasio, 1995). In this context, it thus seems plausible that
the MPFC activation noted here in FA- subjects related to reflective conscious awareness of
the emotional state induced by viewing the negative pictures.
Given the rich interconnection of the insula with regions involved in autonomic
regulation (Cechetto, 1994), we posit that the insular activation seen in FA- subjects during
the viewing of the negative pictures may be a neural correlate of the autonomic changes
associated with the subjective experience of a negative emotion. With respect to the ATP,
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activity of this cortical region have been reported during a variety of negative emotional
states (e.g., sadness, anger, and anxiety) (Chua et aL, 1999; Damasio et al 2000; Dougherty
et aÏ., 1999; KimbrelÏ et al., 1999; Lane et aï., Ï997a; Lévesque et al 2003; Reiman et al.,
1989). This paralimbic region receives inputs from unimodal and heteromodal sensory
regions, as well as limbic inputs. In keeping with the conclusions derived from various
unes of evidence regarding the anterior temporal pole (Mesulam, 1985), we propose that
anterior temporopolar seen in the FA- group was associated with imparting affective tone to
the subjects’ experience.
The amygdala activation noted in FA- subjects is consistent with the results obtained
in previous PET (Schneider et al., 1995; Lane et al., 1997a; Reiman et al., 1997; Blair et al.,
1999) and fMRI (Lévesque et al., 2003; Schneider et al., 1997; Whalen et al., 1998) studies
of negative emotions. The results of these functional neuroimaging studies combined to
various evidence from experimental lesion studies in animals and clinical neuropsychology
in humans strongly suggest that the arnygdala is involved in the evaluation of the emotional
significance of stimuli detected in the external environment (for a review, see Lane, 2000).
In the present context, it seems likely that the amygdala activation measured in the FA-
group during the viewing of the negative pictures was related to the appraisal process of
these stimuli.
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It has been postulated (Mayer et al., 1985) that flat affect in schizophrenia reftects a
dysfunction in the right hemisphere. About hemispheric dominance for emotional
processes, Davidson (1984) suggested that the prefrontal regions of the left and right
hemispheres are specialized for approach (positive emotion) and withdrawal (negative
emotion) processes, respectively. The resuits of the present fMRI study firmly stand against
this view since they suggest that the diverse emotion processes recruited, during the
viewing of emotionally negative pictures, are neurally instantiated by cerebral structures
located flot only in the right hemisphere but in the left hemisphere as well. In une with our
resuits, Wager et al., (2003) recently performed a quantitative meta-analysis on 65
functional neuroimaging studies of emotion. They found no support for the hypothesis of
overail right-lateralization of emotionai function, and very limited support for valence
specific lateralization of emotional activity in the prefrontal cortex. This meta-analysis
clearly demonstrated that lateralization of emotional activity is much more complex than
predicted by previous theories about the fleurai bases of emotion.
A malfunction of the amygdala may be responsible for the reduced emotional
expressiveness seen in some schizophrenias in response to ernotionally-laden visual stimuli
(Berenbaum and Oltmanns, 1992), and the difficulty of schizophrenia subjects with flat
affect to identif’ the emotional valence of visual images (Gur et al., 2002; Paradiso et al.,
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2003). The diminished emotional response found here in the FA+ subjects may also be
related to such a malfunction. It is possible that this malfunction rendered the amygdala
unable to correctly evaluate the ernotional meaning of the pictures presented. Perhaps this
disturbance prevented effective coimectivity linking the amygdala to the brain regions
implicated in the physiological dimension of emotion, such as the midbrain, the insula, and
the ventrolateral portion of the OFC (BA 47). Likewise, from an experiential perspective,
maybe this defect disturbed effective connectivity in the neural networks connecting the
amygdala to the ATP, ACC, and MPFC.
It has also been proposed that flatness of affect in schizophrenia resuits from a
dysftmction of the MPFC and ACC (Weinberger, 1987; Mega et al., 2001; Gur et al.,
2002). In une with theses hypotheses, the resuits of the quantitative comparison between
the FA+ and FA- groups provide support to the view that ftatness of affect in schizophrenia
is related to an abnormal functioning of several limbic/paralimbic brain regions normally
implicated in various dimensions of emotion. Since the midbrain was activated in both
groups during the viewing of the negative pictures, it is likely that the perceptual processing
of these stimuli also lcd to an autonomie response in the FA+ subjects. Perhaps a
disturbance of effective connectivity in the neural networks linking the midbrain and the
medial prefrontal system (which encompasses the 0fC and ACC) (Ongur et al., 1998) —
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which is involved in self-awareness of emotion (Darnasio, 1995; Reiman et al 1997; Lane,
2000) - was responsible for the abnormal functioning of the MPfC (BA 10) and ACC (BA
32), and the quasi absence of emotional reaction in FA+ subjects.
Lastly, we would like to acknowledge some of the limitations of this study. First, the
sample size of our groups was relatively small. Second, no objective measures were
performed to characterize the subjects’ emotional state. histead, self-report ratings were
used. Self-report data are extrernely susceptible to bias. Hence, a more objective measure
would have definitely bolstered the results of this study. Third, the AB block design
without permutation of the conditions restricts the interpretation of the present findings.
Possibly, the expectation of the next block could influence the brain activation pattem of
the present one. fourth, no effective connectivity analyses were conducted between the
amygdala or midbrain and other limbic/paralirnbic brain regions. Given these limitations,
our resuits should be considered as preliminary and awaiting independent replication.
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Abstract
Blood-oxygenation-level-dependent (BOLD) brain changes underlying response to
quetiapine were examined using passive viewing of ernotionally aversive and neutral
stimuli. Twelve DSM-W schizophrenia patients with flat affect/emotional withdrawal
(fA+) (positive and negative symptoms scale + rating scale for emotional blunting) were
scanned before and after 5.5 rnonths of quetiapine treatment. Whole-brain, voxel-based
methods were used to assess response-specific quetiapine effects. A post-hoc comparison to
an independent group of 11 schizoplirenia patients without flat affect/social withdrawal
(FA-) was also performed to interpret the specificity of identified quetiapine effects. A 5.5-
month treatment with quetiapine resulted in significant clinical improvement in the 12
study completers (mean ±SD post-treatment PANSS flat affect score of 5.50 ±0.76 at
baseline to 2.0$ ±1.00 at end point (t7.78, df=11, p<O.0001). Treatment response was
associated with significant BOLD changes both in sub-cortical an cortical structures:
increases in prefrontal cortex activation right dorsolateral prefrontal (DLPFC, BA 46) and
the right anterior cingulate cortex (ACC, BA 32); left putamen, right anterior temporal pole
(ATP) and right amygdala. Conversely, before quetiapine, the same subjects activated only
sub-cortical structures: the midbrain bilaterally and the right pons. The post-hoc
conjunctional analyses demonstrated that FA- subjects activated the left ACC, lefi insula,
left ATP (BA 21), left ATP (BA 3$), left arnygdala and right medial prefrontal cortex.
Quetiapine seems to affect clinical recovery by modulating the functioning of specific sites
from subcortical to cortical regions (i.e., modulating the mesocortical pathway). Unique
BOLD changes in the putamen and DLPFC with quetiapine, in the FA+ post-quetiapine,
relative to other drugs (used by FA-) may reflect modality-specific effects with implications
for understanding mechanisms underlying different treatrnent mechanisms.
Key words: Schizophrenia, negative symptoms, flat affect, functional magnetic resonance
imaging, quetiapine, atypical antipsychotics.
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Introduction
Flat affect/emotional withdrawal deficit in schizophrenia is predictive of a number
of outcome indices, and pose a significant obstacle to any atternpts at social rehabilitation
(Kirkpatrick and Buchanan, 1990; Breier et al. 1991; Keltner and Kring, 199$). It also has
been shown to be a relatively enduring symptom that generally responds poorly to
treatment (Pogue-Geile and Han-ow, 1985). This raises the possibility that treatments
producing improvements in flat affect rnight, in tum, prove to have synergistic effects with
psychosocial interventions. On a related note, treatment with atypical antipsychotic
medications has been reported to improve negative symptoms (Meltzer, 1999; Meltzer et
al., 1999). However, most studies have flot examined specific negative symptoms (i.e., flat
affect) and have not investigated the direct association between changes in a specific
negative symptom and brain functioning.
The critical question, in this paper, is whether quetiapine (an AstraZeneca atypical
antipsychotic) would have a treatrnent specific effect on emotion modulation, by
modulating the sub-cortical/cortical pathway, in schizophrenia patients with flat affect
(fA+) and ernotional withdrawal symptoms. As a first step in addressing this issue, this
study examines changes in blood oxygenation level dependent (BOLD) activity associated
with the passive viewing of aversive pictures. Functional magnetic resonance imaging
(fMRI) BOLD response were contrasted post-hoc with those of a previous study done by
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our group on schizophrenia patients without flat affect/emotional withdrawal symptoms
(FA-) and schizophrenia patients FA+(subrnitted). Noteworthy, we did flot find a
significant difference between FA- patients and normal controls in emotion processing
(Fahim et al., 2003). Therefore, we rneasured neural responses in FA+ to aversive (sadness,
fear, disgust) emotions compared with neutral expressions. These emotional expressions
represent, respectively, displays of social approval, intemal distress, and extemal threat. We
did flot specifically wish to determine the effect of emotional category or intensity per se on
pattems of subcortical and cortical response to these stimuli, since this was beyond the
focus of our study.
Studies employing a variety of techniques have highlighted the importance of specific
subcortical regions in the response to ernotionally salient material (Calder et al., 2001;
Davis and Whalen, 2001), namely, the amygdala, ventral striatum (including caudate
nucleus, ventral putamen, and globus pallidus), midbrain and pons (Pardo et al., 1993;
George et al., 1995; Lane et al., 1997a; Damasio et al., 2000; Beauregard et al., 2001;
Levesque et al., 2003). These regions may be involved both in the identification and
autonomic generation of emotional states (Phillips et al 2003a). There is also increasing
evidence for the role of different regions of ventral and dorsal prefrontal cortex in the
modulation, experience an expression of emotional states in response to emotionally salient
material (e.g., Beauregard et al., 2001; Levesque et al., 2003). In the current study, these
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subcortical, ventral, and dorsal prefrontal regions referred to subsequently as “subcortical
and cortical structures”, were therefore included as regions of interest (ROIs), and between
group differences in BOLD response within activated clusters located within these regions
were examined. Furtherrnore, the extent to which these findings represent symptom-related
activity in schizophrenia patients and the relative magnitude of subcortical and cortical
structures’ responses to quetiapine are discussed.
Based on the notions that (i) stimuli with strong affective content modulates neural
information processing both at the cortical and subcortical levels (Ekman et al., 1994;
Kosslyn et al., 1995), (ii) quetiapine modulates the mesocortical pathway, which projects
from the midbrain and sends its axons to the limbic cortex (Stahi, 2002), (iii) this pathway
is involved in emotion recognition, experience and expression (Lane et al., 1997a; Damasio
et al., 2000) we predicted that:
[1] Pre-quetiapine: schizophrenia patients with flat affect would demonstrate an enhanced
response only in subcortical regions.
t2] Post-quetiapine: schizophrenia patients with flat affect would demonstrate significant
activity both within cortical and subcortical regions.
[3] When using a conjunctional analysis (post-hoc) schizophrenia patients with flat affect
post-quetiapine would flot significantly differ from schizophrenia patients without flat
affect: both groups would reveal subcortical and cortical activation.
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Materials and Methods
Subjects
Twelve FA+ subjects (3 womenl9 men) participated in the study. The Mean age was 27.6
± 8.9 years (range: 20-46) and the Mean level of education 10.4 ± 4.0. The average age of
onset of schizophrenia was 22.3 ± 4.9. Ail subjects gave written informed consent afier a
detailed explanation, and the study was approved by local scientific and ethics committees
(Hôpital Louis-Hippolyte Lafontaine and Centre hospitalier de l’Université de Montréal,
Hôpital Notre-Dame).
Drug Administration
The starting dose of quetiapine was 25 mg adrninistered once daily at bedtime. The dose
was increased in 50 mg increments every two days up to 200 mg every night during the
first week. If symptoms persisted after the first month the dosage was increased to a
maximum of 700 mg!day based on clinical response and tolerability. Concomitant
antipsychotic medications were not permitted. The Mean dose was 529 ± 13 8.9 mg.
Psychiatric Assessments
Subjects were investigated using the patient version ofthe Structured Clinical Interview for
DSM-W ($CID) (1994), the Positive and Negative Syndrom Scale (PANSS) (Kay et al
1986), and the Rating Scale for Emotional Blunting (RSEB) (Abrams and Taylor 1978)
(Table 1). Criteria for entry into the study were a diagnosis of schizophrenia (based on the
DSM-W), no concomitant axis I or axis II disorder, and no medical or neurological disease.
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FA- subjects had a score higher than 17 and FA+ subjects had a score lower than 10 on the
RSEB.
In addition, patients were assessed for depressive symptoms (CDS: Calgary Depression
Scale for $chizophrenia) (Addington et al., 1993), to investigate whether the flat affect
symptom improvement was inftuenced by or due to a change in depressive symptoms.
Before treatment with quetiapine, patients were on the following antipsychotic medications:
haloperidol (N=2; mean dosage: 10 ± 0.0 mg); risperidone (N=9; 3.3 ± 1.4 mg); olauzapine
(N=6; 21.2 ± 6.29 mg). Two patients took two antipsychotic medications, and one took
three.
Behavïoral Procedure
Ail subjects had two fMRI scans (before and after quetiapine treatment). The median
delay between the first and second scans was 5.5-rnonth (mean 5.92 ± 3.14). BOLD signal
changes were measured during two experimental conditions, i.e., an Aversive Ernotional
condition and a Neutral Emotional condition. During the Aversive Emotionat condition, a
series of 44 emotionally-laden aversive pictures (e.g., plane crash, snake, spider, shark,
angry face, sad face, mutilation, accident, hum victim, dead body, dying man, aimed gun,
electric chair, etc.) were presented to the subjects whereas in the Neutral Emotional
condition, subjects saw a series of 44 emotionally neutral pictures (e.g., tourist, rocks, boat,
leaves, outiet, towel, spoon, mug, basket, fan, iron, shoes, fork, umbrella, lamp, plate, chair,
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etc.). The pictures were selected from the International Affective Picture System (lAPS,
Lang et al 1988). They were rnatched as much as possible in terms of visual complexity.
Pre-quetiapine: the mean valence (ranging from pleasant=8 to unpleasant1) was 2.66 ±
1.58 for the aversive pictures and 5.74 ± 1.47 for the neutral pictures; the mean arousal
(ranging from calm=1 to excited=8) was 6.11 ± 2.14 for the aversive pictures and 2.97 ±
2.08 for the neutral pictures. Post-quetiapine: the mean valence was 2.48 ± 1.4$ for the
aversive pictures and 5.23 ± 1.23 for the neutral pictures; the mean arousal level was 6.17
± 2.17 for the aversive pictures and 2.81 + 1.94 for the neutral pictures. Without the arousal
component, affective events are less intense (Lang et al 1988). There was no significant
difference with respect to the mean valence (F=2.14, t=1.32, df=86, p=O.2) ami mean
arousal (F=0.59, t=1.$3, df=86, p=O.85) of the pictures before vs. after quetiapine
treatment. During the functional scan, four blocks of negative pictures and four blocks of
neutral pictures were presented to the subjects. The blocks were presented in an altemating
manner (one block negative, then one block neutral, then one block negative, then one
block neutral, etc.). Each picture was presented for a period of 2.88 s, and each block
—
which lasted 31.68 sec
- comprised 11 pictures. Blocks were separated by resting periods of
14.4 sec, during which subjects viewed a blank cyan screen. Subjects were instructed to
look carefully at each of the $8 picttires presented to them during the functional scan. To
assess the subjective responses of the subjects to the stimuli, immediately at the end of the
rnn, subjects were asked to rate verbally on a subjective rating scale ranging from O
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(absence of any emotional reaction) to 8 (strongest ernotional reaction ever feit in one’s
lifetime), the intensity of emotion feit during the viewing of negative lAPS pictures.
Image Acquisition and Analysis
Echoplanar images (EPI) were acquired on a 1.5 Tesla system (Magnetom Vision,
Siemens Electric, Erlangen, Germany). Twenty-eight suces (5 mm thick) were acquired
every 2.65s in an inclined axial plane, aligned with the AC-PC axis. These 12* weighted
functional images were acquired using an EPI pulse sequence (TE = 44 ms, Flip = 90°,
FOV = 215 mm, Matrix = 64 x 64, Voxel size = 3.36 mm X 3.36 mm X 5 mm). Following
functional scanning, high-resolution data were acquired via a Tl-weighted three
dimensional volume acquisition obtained using a gradient echo pulse sequence (TE 44
ms, Flip = 12 FOV = 250 mm, Matrix = 256 x 256, Voxel size = 0.94 mm3).
Data were analyzed using Statistical Parametric Mapping software (SPM99,
Wellcome Department of Cognitive Neurology, London, UK). Images for all subjects were
realigned to correct for artifacts due to srnall head movements. The gradient-recalled echo
planar sequence that we used is associated with large static magnetic field inhomogeneities
commonly found near air/tissue interfaces (Cordes et al 2000). These inhomogeneities can
create artifacts like signal loss and voxel shifts in the ventral frontal, medial temporal, and
inferior temporal regions (Song et al 2001). b correct for such artifacts, a mask was
applied to the slices of the mean EPI image that presented signal loss. This procedure was
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implemented for every subject. The images for ail subjects were then spatialiy normalized
into an MRI stereotactic space (Talairach and Toumoux 1988) using this masked mean
image. Images then were convoived in space with a three-dimensionai isotropic gaussian
kemel (12 mm FWHM) to improve the signal-to-noise ratio and to accommodate for
residual variations in functionai neuroanatomy that usuaiiy persist between subjects after
spatial normalization.
For the statistical analysis, the time series of the images were convolved with the deiayed
box-car function, which approximates the activation pattems. Effects at each and every
voxel were estimated using the general linear model. Voxel values for the contrasts of
interest yielded a statistical pararnetric map of the t statistic (SPM t), subsequentiy
transformed to the unit normai distribution, (SPM Z).
A “fixed-effects model” was impiemented to contrast the brain activity associated
with the viewing of the aversive pictures and that associated with the viewing of the
emotionally neutral pictures (Aversive minus Neutral). This “fixed-effects model”
produced individual contrast images, which were used as raw data for the implementation
of a “random-effects modei”, which takes into account intersubject variance and permits
population-level inferences (Friston and frackowiack 1997). Within such “random-effects
model”, and using these individuai contrast images, a one sampie t-test then a two-sample t-
test were carried out, voxel-by-voxel, to directiy compare the mean BOLD response
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between the two groups of subjects (aversive minus neutral for the same group then FA+
group minus FA- group and FA- group minus FA+ group, respectively) with regard to the
Aversive minus Neutral contrast. Such randorn-effects model was used in this study,
because this model takes inter-subject variability into account, thus it can be used with
large samples of subjects to make inferences at the population level. A sample size of $ to
16 subjects is usually considered sufficient for random-effects analyses to be used (friston
et al., 1999). Using this model, if inter-subject variability is important for a given locus of
activation (relative to average activation), this activation will be considered insignificant.
This would not be the case with fixed-effects analyses, in which inter-subject variability is
not considered (Friston et al., 1999).
An à priori search strategy was used, and a small volume correction was performed in the
brain regions of interest (ROI) defined à priori. The search volume corresponding to the
ROIs was defined à priori, using srnall volume correction (SVC) and box volume function
in SPM99, and based on the neuroanatomic boundaries of these regions noted in the MR
reference image (Montreal Neurological Institute (IvINI) template) and the Talairach and
Toumoux (1988) atlas. For this à priori search, a probability threshold for multiple
comparison of a corrected P<0.05 was used. Only clusters showing a spatial extent of at
least five contiguous voxels were kept for image analysis. The à priori search strategy
encompassed the orbitofrontal cortex (OFC Brodmaim’s areas (BA) 11; box-center situated
at 30,28,-16 mm bilaterally; box-volurne= 44,25,16), the anterior cingulate cortex (ACC
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BA 32; box-center situated at 4.5, 22.5, 29 mm bilaterally; box-volume= 13, 40, 53), the
medial prefrontal cortex (MPFC BA 10; box-center situated at 2.5, 50, 22 mm bilaterally;
box-volume= 5, 10, 32), the anterior temporal pole (ATP BA 21; box-center situated at 56,
Û
-23.5, -2 mm bilaterally; box-volume= 8, 10, 19), the anterior temporal pole ( ATP BA 38;
box-center situated at 40, 10, -22 mm bilaterally; box-volume= 20, 12, 34), the insula (box
center situated at 39, -2, -6 mm bilaterally; box-volume= 4, 32, 2), the amygdala (box
center situated at 21, -2, -14 mm bilaterally; box-volume= 8, 10, 11) and the midbrain (box
center situated at 6.5, 8, -6.5 mm bilaterally; box-volume= 10, 25, 12). These brain regions
have been found activated on a more or less consistent basis in previous functional
neuroimaging studies of aversive emotional states (for a complete review please refer to
Phan et al., 2002; Eugene et al., 2003).
To assist in interpjeting any identified BOLD changes afler quetiapine treatment,
several additional post-hoc analyses were performed to investigate the potential effect of
quetiapine on emotion modulation. BOLD changes with response to the 5.5 months
treatment with quetiapine were statistically contrasted to those seen in a previously
acquired data set of comparably recruited schizophrenia patients without flat
affect/emotional withdrawal symptoms (FA-) (n = 11; mean ± SD age, 25.7 ±4.4, range 21-
37 years, mean schizophrenia age of onset 21.3 ±2.7, mean years of education 10.4 ±2.6)
who had been similarly scanned: same fMRI machine, same block design, same run, same
pictures. In the absence of a controlled randomized trial, this set of post hoc analyses
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provided a critical perspective for interpreting the main quetiapine response findings. A
fixed-effects model was implernented to do the conjunctional analysis. The contrasts
(aversive minus negative) for 23 subjects (FA+ post quetiapine n12 plus the FA- n=1 1,
total n=23) were selected to yield the total conjunctional analysis using the SPM99 “define
new contrast” in the SPM contrast manager window.
o
Resuits
Psychiatric assessment data
A 5.5-month treatment with quetiapine resulted in significant clinical improvernent in the
12 study completers (mean ±SD post-treatment PANSS flat affect score of 5.50 ±0.76 at
baseline to 2.0$ ±1.00 at end point (t=7.78, df=11, p<O.0001). Interestingly, the difference
in the CDS was insignificant p<O.23.
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Table 1. Results of psychiatrie assessment tests in schizoplirenia patients wïth flat affect
pre and post-quetiapine.
Mean score and SD Mean score and SD p value
fA+pre N=12 FA+post N12
RSEB 19.86±1.70 4.08 ±1.40 0.0001*
PANSS: Flat affect 5.50 ±0.76 2.08 ±1.00 0.0001*
PANSS: Emotional withdrawal 5.00 ±1.04 2.08 ±0.90 0.0001*
PANSS: positive symptoms 2 1.43 ±6.87 16.08 ±6.88 0.13
PANS$: negative symptoms 3 1.29 ±5.09 17.50 ±4.81 0.0001*
PANSS: total 102.43 ±13.81 68.50 ±17.57 0.0001*
CDS 6.27 ±4.7 1 4.00 ±4.17 0.23
Table 2. Results of psychiatrie assessment tests
Mean score and SD Mean score and SD p value
FA+ FA
RSEB 19.86 ±1.70 6.00 ±1.41 0.0001
PANSS: Flat affect 5.50 ±0.76 1.45 ±0.82 0.0001
PANSS: Emotional withdrawal 5.00 ±1.04 1.73 ±0.90 0.0001
PANSS: positive symptoms 3.09 ±1.38 3.23 ±1.3 1 0.56
PANSS: negative symptoms 4.4$ ±1.04 2.05 ±0.95 0.02
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PANSS:general psychopathology 3.06 ±1.24 2.53 ±1.08 0.33
PANSS: total 3.40 ±1.23 2.59 ±1.10 0.31
CDS 6.7±4.53 4.1 ±3.71 0.12
Table 2. CDS: Calgary Depression Rating Scale; PANSS: Positive and Negative
Symptoms Scale; RSEB: Rating Scale for Emotional Blunting.
Table 3. Resuits of psychiatric assessment tests in schizophrenia patients with flat affect
post-quetiapine and schizophrenia patients without flat affect.
Mean score and SD Mean score and SD p value
FA+postNl2 fA-N=11
PANSS: Flat affect 2.08 ±1.00 1.45 ±0.82 0.12
PANSS: Emotional withdrawal 2.08 ±0.90 1.73 ±0.90 0.35
PANSS: positive symptoms 16.08 ±6.88 22.64 ±5.50 0.19
PANS$: negative symptoms 17.50 ±4.81 14.36 ±4.25 0.22
PANSS: total 68.50 ±17.57 77.55 ±14.92 0.34
CDS 4.00 ±4.17 4.1 ±3.71 1.00
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Self-report data
Experientially, pre-quetiapine, viewing of the aversive pictures did flot induce a aversive
emotional state (1.79 ±2.00). Conversely, post-quetiapine viewing ofthe aversive pictures
induced a aversive emotional state whose intensity was significantly greater than pre
treatment (6.67 ±0.78) (F=4.15, t=-7.91, df=22, p=O.000l) on a scale vaiying from O-no
emotion feit to 8-highest emotion feit in one’s life. In fact, patients demonstrated
considerable insight into their feelings. This is in accordance with their insignificant
difference on the sub-syrnptom, lack ofjudgement and insight, on the PANSS score (fA+
before 3.10 ±0.99; FA+ after 2.50 ±1.24; pO.23).
JMRI Data: Subtraction Approach
Pre-quetiapine. Significant locus of activation was noted in subcortical structures: in
the midbrain bilaterally and right pons when the brain activity associated with the viewing
of the emotionally neutral pictures was subtracted from that associated with the viewing of
the emotionalÏy aversive pictures (Aversive minus Neutral contrast) (Table 3 and Figure 1).
JMRIData: Subtraction Approach
Pre-quetiapine. Significant locus of activation was noted in subcortical structures: in
the midbrain bilaterally and right pons when the brain activity associated with the viewing
of the emotionally neutral pictures was subtracted from that associated with the viewing of
the emotionally aversive pictures (Aversive minus Neutral contrast) (Table 3 and figure 1).
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Table 4. Regional brain actïvity in FA+ schizophrenia patients:
Schizophrenia patients FA+ pre quetïapine, contrast = aversive minus neutral
Brain region Brodmann’s Coordinates Voxels z score Corrected
area x p value
Right midbrain 18 -21 -9 33 4.03 0.003
Leftmidbrain -18 -24 -4 10 3.67 0.01
Rightpons 12 -33 -26 19 3.61 0.03
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Figure 1
Post-quetiapine. The Aversive minus Neutral contrast revealed significant loci of
activation both cortical and subcortical: in the lefi putamen, right dorsolateral prefrontal
cortex (DLPFC BA 47), right anterior temporal pole (ATP, BA 38), right amygdala, and in
the right anterior cingulate cortex (ACC, BA 32). (Table 4 and Figure 1).
130
Table 5. Regional braïn activity in FA+ schïzophrenia patients:
Schizophrenia patients FA+ post quetïapine, contrast = aversive minus neutral
Braïn region Brodmann’s Coordinates Voxels z score Corrected
area p value
Lefiputamen -27 -17 -4 22 4.30 0.004
Right DLPFC 46 47 29 9 65 4.19 0.01
RightATP 38 29 -3 -8 33 3.48 0.03
Ramygdala 25 -1 -11 20 2.95 0.05
RightACC 32 8 14 40 11 2.89 0.04
Schizophrenia patients without flat affect. Significant loci of activation were noted in
the lefi ACC (BA 32), left insula, left ATP (BA 21), left ATP (BA 3$), lefi amygdala, right
media! prefrontal cortex (Table 5).
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Table 6. Regional braïn activity in FA- schizoplirenia patients:
Schizophrenia patients FA-, contrast = aversive mintts neutral
Brain region Brodmann’s Coordinates Voxels z score Corrected
area P value
LACC 32 -$ 16 37 22 4.13 0.01
Linsula -36 8 -13 12 4.11 0.01
LATP 21 -45 2 -23 13 4.04 0.01
LATP 38 -48 10 -26 13 3.77 0.05
Lamygdala -25 -7 -11 9 3.72 0.003
RMPFC 10 3 56 19 7 3.57 0.01
Conjunctional analysis (FA+ post-quetiapïne n=12 pttts FA- n=11, total n=23). The
Aversive minus Neutral contrast showed significant loci of activation in both cortical and
subcortical: in the right middle prefrontal cortex (RMPfC, BA 10), right fusiform cortex
(BA 37), right thalamus, right middle prefrontal cortex (RMPFC, BA 9), right putamen,
right midbrain and left amygdala. (Table 6).
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Table 7. Regional brain activity in FA+ pttts FA- post-quetiapine schïzophrenia
patients (Fixed-effects conjunctional analysis): coittrast = aversive minus neutral
Braïn region Brodmann’s Coordinates Voxels z score Corrected
area x y z p value
RMPFC 10 35 23 4 19 6.39 0.0001
Rfusiform 37 3$ -49 -7 100 6.07 0.0001
R thalamus 20 -29 -1 135 6.05 0.0001
RMPFC 9 38 9 24 30 5.56 0.001
RPutamen 29 -17 -1 48 5.31 0.002
Rmidbrain 2 -33 -2$ 14 4.97 0.01
L amygdala -20 -6 -12 5 3.61 0.005
JMRI Data: A Posteriori Corretatioiz Analyses
Correlational analyses were conducted a posteriori between self-report ratings and BOLD
signal increases found in the ROIs. These analyses revealed the existence of a positive
correlation in the right putamen (coordinates of maximum = (19, 6, 10); z= 2.94; pO.OO2,
uncorrected; 12 voxels); right ATP (BA 3$; coordinates of maximum = (33, 2, -23); z=
2.6$; pO.004, uncorrected; 23 voxels) and the right medial prefrontal cortex (MPFC BA 9;
coordinates of maximum = (6, 56, 27); z= 2.52; pO.OO6, uncorrected; 45 voxels). This
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simple regression analysis was done using the basic models-simple regression correlation
analysis function in SPM 99 allowing us to correlate the subjective rating scale score (of
the patients’ experience of emotion feit during the scan), with the aversive-minus neutral
condition using the one-sample t-test after quetiapine.
Discussion
While far from being conclusive, findings from the present exploratory study suggest that a
daily mean dose of 529 ±138.9 mg quetiapine potentially bas a positive effect in treating
flat affect symptoms in schizophrenia patients. On one hand, post quetiapine subjects rated
the pictures as more emotional. On the other hand, quetiapine modulated the
subcortical/cortical pathway.
The neurobiologicat corretates ofemotion processing: froin subcorticat to cortical
A distinctive and important feature ofthe ernotional behavior ofhumans is the diversity and
complexity of emotional strategies. That is, in contrast to lower mammals, changes in our
emotional state are flot only triggered by the situation through the autonomic nervous
system (subcortical structures), but also further analyzed (cortical structures). Clearly, the
evolutionaiy process of the cerebral cortex development resulted in a corticalisation of
emotional as well as higher social functions, which further analyses and decides upon the
reaction to the emotional situation. Thus, setting the mood and modulating emotion based
on past or anticipated future consequences ofbehavior.
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Sorting these principles out is important because of the potentially beneficial effects of
quetiapine in improving flat affect symptoms through its modulation of the
subcorticallcortical structures involved in emotion processing. Before quetiapine treatment,
the passive viewing of the aversive pictures revealed significant loci of activation in the
midbrain bilaterally and the pons. Some evidence suggests that these cerebral structures are
involved in the mediation of autonomic responses such as skin conductance responses
(Sequeira and Roy, 1993) and body temperature changes (Nagashima et al., 2000). Given
that autonomic responses often accompany the autonomic experience of primary emotions
(Damasio et al., 2000), the bilateral rnidbrain activation noted here may be related to the
autonomic responses associated with subject& perception of lAPS images. However, this
autonomic state was “lost in translation” from the midbrain to the prefrontal cortex. We
interpret these findings as suggesting, at the biological level, an underactivation of weakly
connected networks in FA+ schizophrenia patients from the midbrain to the prefrontal
cortex. These findings also suggest that a key elernent of any network is its ability to
maintain stability and control excitation. An emotional situation produces various levels of
excitatory buildup. Hence, it could be argued that FA+ schizophrenia patients may produce
a dysregulation of this network because of failure of excitation from the midbrain to the
prefrontal cortex.
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Post-quetiapine, significant loci of activation were reveaied in both subcortical and
cortical structures. The amygdala is involved in the evaluation of the emotional significance
of stimuli detected in the external environrnent (for a review, see Lane and Nadel 2000). In
the present context, it seems plausible that the amygdala activation measured during the
viewing of the aversive pictures was related to the appraisal process of these stimuli. With
respect to the activation observed in the anterior temporopolar cortex, activity of this
cortical region has been reported during a variety of aversive emotional states (e.g.,
sadness, anger, and anxiety) (Chua et aÏ.,1999; Damasio et al 2000; Dougherty et al., 1999;
Kimbreli et al., 1999; Lane et al., 1997a; Lévesque et al 2003; Reiman et al., 1989). This
paralimbic region receives inputs from unimodal and heterornodal sensory regions, as weii
as limbic inputs. In keeping with the conclusions derived from various unes of evidence
regarding the anterior temporal pole (Mesulam 1985), we propose that anterior
temporopolar seen here was associated with imparting affective tone to the subjects’
experience. The anterior cingulate cortex plays a pivotai role in the interoceptive and
exteroceptive detection of emotional signais (Lane et al 1997b). Activation ofthe DLPFC is
of particular interest. This area is involved in looking up information in rnemory (perhaps
as associations and emotion recognition ofthe visible pictures) (Kosslyn et ai., 1995). The
unique changes in the putamen activity with treatment response are noteworthy, as they
support a critical role for emotion modulation with quetiapine response compared with the
FA- group. Although both groups dernonstrated similar loci of activation, only FA+
subjects post quetiapine were associated with putamen activation. Furthermore, this region
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correlated with the subjective rating score of emotions feit during the scan, post-quetiapine.
Activation of the putamen previously bas been associated with emotional processing tasks
in normal control participants, including the active rethinking and reappraisal of emotional
feelings (Pardo et al., 1993; George et al., 1995; Lane et al., 1997a; Damasio et al., 2000).
The positive conelation found between average ratings of aversive emotion and
BOLD signal increases in the MPFC is in une with the positive correlation noted
previously (Lévesque et al 2003) between the magnitude of sad feelings and BOLD signal
increases in the same part of the MPfC. This prefrontal cortical region receives sensoiy
information from the body and the extemal cnvironment via the orbitofrontal cortex and is
heavily interconnected with limbic structures, such as the amygdala, hypothalamus,
midbrain periaqueductal gray region, and brainstem autonomic nuclei (Barbas 1993;
Carmichael and Price 1995). It is noteworthy that a region of the medial prefrontal cortex
close to that identified in this study has been implicated in metacognitive representation of
one’s own emotional state (Lane 2000; Reiman et al 1997). In keeping with this, studies of
individuals with damage to the medial prefrontal cortex suggest that this cortical area is
involved in the conscious monitoring of the individual’s emotional state (Damasio 1995).
In this context, it thus seems plausible that the medial prefrontal noted here is related to
reflective conscious awareness of the emotional state induced by viewing the aversive
pictures. Overall, on one hand, sub-cortical structures could be responsible for registering
bodily responses ta aversive stimuli. On the other hand, cortical structures may be involved
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in the modulation, experience and expression of these ernotions. the question now poses
itself: what happened during this 5.5 months period between the two scans that modulated
the neural processing of emotional information from the sub-cortical to cortical structures?
Possible mechanism of action of quetiapine in improving flat affect: the mesocortical
pathway
The preceding section highlighted the role that quetiapine may play in improving flat affect
symptoms by modulating different brain regions involved in emotion processing. Going
one step fiirther, in this section we will discuss quetiapine proposed mechanism of action.
On theoretical grounds, typical doparnine D2 antagonists generally have no beneficial
effect on schizophrenia negative symptoms and may even be detrimental to some of the
cognitive, social and affective functions (Shanna, 1999). In contrast, accumulating data
suggest that second generation antipsychotic agents (atypical) ameliorates some cognitive
and negative deficits in schizophrenia patients (sec Meltzer and McGurk, 1999 for review).
Yet, relatively little is known about the mechanisms that mediate a specific negative
symptom-enhancing effect of atypical antipsychotics, as is the case of flat affect in this
study. In this vein, it was suggested that a preponderance of the serotonin (5-HT)-2A
antagonism over D2 blockade exerted by atypical antipsychotics may enhance
dopaminergic output in the prefrontal cortex and may thus account, at least in part, for their
beneficial cognitive effects in schizophrenia (Ruiu et al., 2000; Ichikawa and Meltzer,
1999; Williams et al., 2002). In an elegant description of how 5-HT2A antagonism could
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enhance prefrontal dopamine output, Van Oekelen and colleagues (2003) stated that the
piriform cortex lias a population of GABA-ergic interneurons that are excited by activation
of 5-HT2A receptors (Marek and Aghajanian, 1992; Morilak and Ciaranello, 1993; Morilak
et al., 1993). Consequently, 5-HT2A receptor antagonists, i.e, antipsychotics with this
property prevent the stimulation by 5-HT of cortical GABA-ergic intemeurons. The
reduction in cortical GABA-release attenuates the inhibitory effect of GABA-ergic
interneurons on glutamergic neurons (Bergson et al., 1995; Carlsson et al., 1997). The
increased activity of cortical glutamatergic neurons enhances the glutamate release from
cortical afferents to the ventral tegmental area (VTA), resulting in an increase in
dopaminergic neuronal firing (Bergson et al., 1995; Carlsson et al., 1997; Pehek et al.,1996;
Svensson et al., 1993). The increased activation of dopaminergic neurons projecting to the
frontal cortex increases the cortical dopamine release, leading to stimulation of cortical
dopaminel (Dl) receptors (Bergson et al., 1995; Williarns and Goldman-Rakic, 1995). This
finding is veiy intriguing, and it may explain the mechanism of action of quetiapine in
reducing flat affect symptom. Hence, we suggest that the higher ratio of serotonin (5-
HT2A) receptor to doparnine (D2) receptor antagonism may have played a role. A higher
ratio of 5-HT2A to D2 receptor binding may be associated with improving negative
symptoms and reduced frequency of extrapyrarnidal symptoms (Meltzer et al., 1989;
Ichikawa et al., 1999). A recent preclinical study suggests that atypical antipsychotics may
dampen neurotransmitter function in the mesolirnbic/mesocortical tract and may facilitate
neurotransmission of various transmitters (dopamine, serotonin) in anterior
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limbic/prefrontal cortical regions (Meltzer, 2004). 0f particular relevance to our study, the
mesocortical dopamine pathway projects to areas of the cerebral cortex, such as the
DLPFC, and the limbic cortex (Pehek et al., 2001).
Relatedly, quetiapine is an effective 5-HT2A and D2 receptor antagonist (Gefvert et
al., 1998) and has been reported to be a 5-HT lA receptor partial agonist, increasing DA and
ACh release in the prefrontal cortex (see review in Sharma, 2001). It is noteworthy that
quetiapine 5-HT2A antagonisrn flot only reverses D2 antagonism but causes a net increase
in dopamine activity in the mesocortical doparnine pathway (Gobert and Miller, 1996;
Pehek et al., 2001). This pathway lias long been considered critical in the processing of
complex emotional beliaviors (James, 1884; Papez, 1927; MacLean, 1949; Rolis, 1990;
Damasio, 1996). Comparative anatomical studies provide material support for this
hypothesis. Reciprocal pathways linking limbic structures (anterior cingulate, amygdala)
with widely distributed brainstem, striatal (putamen), and neocortical sites are now well
defined (Carmichael and Price, 1995), and clear associations with specific emotional
behaviors have been demonstrated (for a complete review refer to Phan et al., 2002). By
extrapolation, these regions are also assumed to be the neural substrates responsible for the
systematic integration of exteroceptive and interoceptive inputs required for the combined
sensory, cognitive, and autonomic processing at the core of normal and abnormal human
emotional experience. Based on these findings, we propose tliat quetiapine exerted a
combined bottom-up and tôp-down mechanisms in ameliorating flat affect symptoms in our
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population by “normaÏizing” the function of the mesocortical dopamine pathway. The
prefrontal cortex and anterior limbic regions are of special interest because of their
involvement in ernotion regulation and expression. Before quetiapine treatment
schizophrenia patients fA+ activated the rnidbrain and pons, without showing any
significant activation in the mesocortical pathway involved in emotion processing.
However, during quetiapine treatment, the second scan revealed (j) significant activation of
this pathway (Table 3-figure 1 and 2), (ii) improvement in flat affect/emotional withdrawal
symptoms (Table 1), (iii) subjects rated the pictures as emotional.
The tolerability of quetiapine was excellent. In several cases, parents confirmed the
patient’s report of improved symptoms. Patient tolerability xvas further reflected, at least in
part, by the high retention rate in this trial. Furthermore, the improvernent in core flat affect
re-experiencing symptoms is especially noteworthy because these particular symptoms are
ofien the most refractoiy to treatment. Overali a positive response to quetiapine is notable
as this was a chronic and relatively treatment resistant clinical population.
Conclusion and Limitations
Overall a positive response to quetiapine is notable as this was a chronic and relatively
treatment resistant clinical population. Despite the absence of a prospective, randomized
study design, we have attempted, using the post-hoc conjunctional BA- comparison to
provide some dues for further brain activation in response to emotional stimuli. The 2
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groups were studied as independent cohorts, yet they met identical inclusion criteria, and
were recruited through the same media outiets (Louis H-Lafontaine Hospital). Most
notably, the conjunctional analyses demonstrated a complex set of a similar pattem, of
brain activation, between BA+ (post-quetiapine) and BA-. Most significant, in contrast to
the BA- increases in putamen activation was only noted in the BA+ group during
quetiapine treatment. This could be associated with the known quetiapine profile in
demonstrating fewer extrapyramidal side-effects and reversing D2 blockers in the striatum
(Review in Sharma, 2001). The results ofthis study need to be considered in the context of
several potential limitations: the relatively small sample size, non-blind and open label
design, thus the fMRI alterations could be due to time. It is therefore difficuit to ascertain
whether the differential brain activation was only due to quetiapine treatment or to the time
difference between the two scans. Further studies, using randomized, controlled and
double-blind methodology are needed to further investigate the potential effect of
quetiapine in treating blunted affect symptoms in schizophrenia.
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Discussion
It should be noted that we do not suggest any categorical subtypes of schizophrenia
patients based on the with flat affect/without flat affect symptornatology. However, our
findings, demonstrating differential haemodynamic flow between schizophrenia patients
with and without flat affect, mean that the quest for the syrnptom-specific-neuropathology
of schizophrenia could help explain the multiplicity of neuro-circuit dysfunction in this
heterogeneous disorder. furthermore, we suggest that a daily mean dose of 529±138.9 mg
quetiapine could have a role in improving flat affect/ernotional withdrawal symptoms in
schizophrenia patients.
1. Neuroimaging emotional experience and potential treatment in schizoplirenia:
What we have found.
We interpret our findings (based on the three articles) as suggesting, at the biological
level, an underactivation of weakly coimected networks in FA+ schizophrenia patients from
the midbrain to the prefrontal cortex, through the amygdala. This could establish an
important Iink between experirnental findings and the clinical phenornenology of
schizophrenia. However, FA- displayed similar activation of the key brain regions involved
in emotion processing, which coincides with their experiential response. I wiII now discuss
the role each brain region played in emotion processing starting with emotion perception in
the visual cortex to emotion modulation in the prefrontal cortex.
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1.1. Ihe visual cortex
The perception of a stimulus, through the visual cortex, can result in an emotional
response (Adolphs, 2002). However, modulation of perception by emotion has been more
difficult to demonstrate, because of the multiplicity of neuronal circuits involved. 0f
particular relevance to this thesis, Taylor et al., (2005) reported, using PET, that
schizophrenia patients showed reduced modulation of visual cortex by salient
stimuli. Their resuits showed that patients with schizophrenia exhibit impaired
neural responses to emotionally salient stimuli in the ventral striatum and amygdala,
supporting a role for these structures in the pathophysiology of the ilÏness.
Moreover, reduced modulation of visual cortex by emotionally salient stimuli also
suggests a fallure to organize cerebral activity at a global level.
1.2. Mïdbrain
William James (1884) proposed that stimuli that provoke emotion induce changes in
the viscera and that the self-perception of these visceral changes is what produces
ernotional experience. However, before producing this experience, one should choose the
appropriate emotional strategy. Several recent studies have provided evidence that the
midbrain has been identified as a region containing distinct neural substrates, which
triggers an emotional strategy, i.e., active versus passive/avoidant (Behbehani, 1995;
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Bandier et al., 2000). for example, if confronted with faces expressing negative emotions
(fear, despair, anger, disgust, sadness) it is often appropriate to intervene or escape (i.e.,
choose an active or avoidant strategy).
In a recent study in the macaque, the authors (Bandier et al., 2000), examined the
coimections of the orbital-mesial prefrontal cortex with the brainstem (midbrain). A series
ofretrograde and anterograde tracing experiments revealed that projections to and from the
brainstem arose predominantly from the mesial prefrontal cortex (Brodmann’s area 9/10),
orbital and anterior cingulate cortices. Hence, they are interconnected reciprocally. In other
words, the midbrain bas long been recognized as a structure that integrates somatic,
autonomic, and sensory components of emotional behavior (for a historical review see
Bandler, 1988). Specifically, in a recent study, Damasio and colleagues (2000)
demonstrated that neural activation was observed in the prefiontal cortex, anterior cingulate
gyrus and brainstem for sadness and anger, the midbrain was active in anger and fear, and
both sides of the midiine cerebellum were significat1y activated for sadness, anger and
fear.
The brainstem is the source of several ascending neural pathways, each of which
originates in distinct sets ofnuclei. These pathways, which reach widespread regions ofthe
cortex, affect the operations of the cerebral cortex both by modulating aspects of its overail
activity and by conveying t8 specific regions the contents with which a subjective sense can
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be created (Bandier and Shipley, 1994). This may account, at least in part, for the
differences in our FA- group resuits compared with fA+ (i.e., the differences in the
selection of emotional coping strategies). The fA+ group would ‘prefer’ an avoidant
emotional strategy, hence, no transmission of information to the prefrontal cortex. In
contrast, the FA- group would ‘choose’ the active emotional coping strategy and would
transmit the information to the prefrontal cortex. This view is consistent with other
experimental findings, most notably those who have demonstrated that the rnidbrain lias is
a region containing distinct neural substrates whicli triggers an emotional strategy, i.e.,
active versus passive/avoidant (Behbeliani, 1995, Bandler et aÏ., 2000). 0f particular note,
several research groups (Cari-ive et al., 1997; Dielenberg et al., 2001; Comoli et al., 2003)
have reported that the midbrain may be a component of a circuit that triggers emotional
coping in response to psychological (i.e. cortical) stress. Consistent witli this suggestion is a
recent report stating that for the rat, the presence of (but not contact with) a natural predator
(i.e. a cat), whicli triggers stress, evokes very strong Fos expression (the expression of
immediate-early genes as markers of neuronal activation) within the midbrain (Canteras
and Goto, 1999). Along these unes, the midbrain was found to evoke passive/avoidant
emotional coping strategies (quiescence, immobility, hyporeactivity) that were
characterized by disengagement or withdrawal from the extemal environment and
sympathoinhibition (hypotension, bradycardia) (Bemard and Bandler, 1998; Bandler et al.,
2000). 0f relevance to the previous findings, feedback from bodily responses to an
emotionally salient stimulus is of primordial importance in deterrnining the nature and
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extent of emotional feeling (Jarnes, 1884; Cannon, 1929). Furthermore, brainstem regions
share a major feature in that they are ail indirect recipients of signais from the extemal
milieu and generate regulatory signais necessary to maintain homeostasis (Damasio et al.,
2000; Davidson and kwin, 1999). Hence, brainstem processing of ernotions is perhaps flot
directly accessible to consciousness. This suggests that this kind of activation in the fA+
group may be related to a particular physiological program that prevents them from feeling
emotions. In support of this interpretation, is the important functions that are classically
associated with the brainstem (defensive reactions in response to threatening or nociceptive
stimuli) trigger distinct co-ordinated pattems of skeletal, autonomic and antinociceptive
adjustments by selectively targeting specific midbrain circuits. The intriguing function
attributed to the brainstem, i.e., emotional processing, becomes less intriguing when it is
seen in the perspective of horneostasis, the ultimate physiological role of the human body
and mmd. From a psychodynamical view, we are proposing a repression mechanism used
by the FA+ group to suppress emotions. The question ‘why’ are they using such a
mechanism needs further investigation (see section 2 in the discussion).
1.3. The Insula
The insular cortex is a highiy developed mesocorticai structure that is a major
component of the limbic system (Mesulam and Mufson, 1982). By virtue of its connections
with cortical and subcortical regions, it constitutes a sensory integration region and plays an
important role in human emotion (for a review, see Augustine, 1996). In this review, the
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author lias reported that connections have been described between the insula and the orbital
cortex and the frontal operculum. Specificaliy, it has an abundance of local intrainsular
connections and projections to subdivisions of the cingulate gyrus. The insula lias
connections with the laterai, lateral basal, central, cortical and mediai amygdaloid nuclei.
Furthermore, confirmation lias been given to the insula as a visceral sensory area, hence, is
engaged in tasks that depend on interactions between the extrapersonal world (e.g.,
emotional stimuli) and the internai milieu (Mesulam and Mufson, 1982). Interestingly,
difficulties in distinguishing between representations of internai versus external
perceptions, or actions, have been linked to psychotic symptoms in schizophrenia (Frith and
Dolan, 1997). 0f particular relevance to our study, the paralimbic insular cortex is involved
in the expression of autonomie pattems in response to affective stimuli, and in the
integration of sensory events with appropriate ernotional responses (Mesulam and Mufson,
1982). lndeed, functional imaging studies have shown that the insular cortex is engaged in
ernotional responses to sensory stimuli (Reiman et al., 1997). Thereupon, we suggest that
abnormaiities in the insuiar cortex rnight underiy the abnormai peripheral and behavioral
responses to emotional stimuli that have been described in schizophrenia FA+. We
therefore propose that abnorrnaiities in the insular cortex and its connections with pivotai
other limbic regions may have played a role leading to the failure in the normai emotional
process that permits patients to adapt between internaily (autonomic and viscerai
information) and externally generated sensory events (emotional stimuli depicted by the
lAPS pictures) in schizophrenia fA+. This inadaptation may lead, at ieast in part, to “non
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emotional response” or flat affect seen in FA+. This hypothesis is consistent with the notion
that the insulo-orbito-temporal component of the paralimbic brain is considered an
integrated unit ofcerebral organization involved in emotion (Mesulam and Mufson, 1982).
1.4. The amygdala
The descending sympathetic neurons receive projections from the hypothalamus, and
the hypothalamus receives projections from the arnygdala. Worth mentioning, in regard to
the feedback theory of visceral information to the brain, the major nerve that carnes
visceral afferent information back to the brain is the vagus. These vagal afferents terminate
in the midbrain, which then projects to the central nucleus of the amygdala, which projects
to the rest of the amygdala and insula. The amygdala and insula then project to several
neocortical areas including the temporal, parietal and frontal lobes inputs (reviewed in
Heilman and Gilmore, 1998). Hence, in this manner the amygdala may directly influence
the expenience of emotion, especially considering the fact that it also receives neocontical
input. However, we should bare in mmd that the amygdala is not acting in a vaccum.
Stimulation of other areas, including the insula and orbitofrontal cortex, can also induce
autonomic and visceral changes, and these structures also receive input from the neocontex,
hence influencing emotional experience.
Patients presenting enduring poverty of speech, flat affect, diminished social drive,
and diminished sense ofpurpose have been noted to have lesions ofthe amygdala (Scoville
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et al., 1953; Jacobson, 1986). Further evidence on the role of the amygdala in flat affect
cornes from neuroethological studies. Bilateral lesions of the arnygdala cause mammals to
present flat affect symptoms with a clear lack of social drive and poverty of vocalizations
(which resembles poverty of speech) (Kiing, 1972; Ploog, 1981). Thus, the features of
amygdalar lesions suggest that diminished social drive, flat affect, and poverty of speech
may have a common neural basis, and that this constellation of attributes may represent
appropriate aspects of the definition of a negative symptom subtype (Carpenter et al.,
1991). Interestingly, ferrier and colleagues (1983a) found that Type II patients, which
predorninantly have flat affect and poverty of speech (according to Crow, 1985), had less
cholecystokinin immunoreactivity in the amygdala and hippocampus than did control,
whereas Type I (without flat affect) patients did flot differ from controls. These researchers
concluded that the selectivity of these changes to limbic lobe may reflect the presence of a
degenerative process in that area. Furthermore, Ferrier et al., noted that the association of
changes in hippocamptis and amygdala with negative syrnptoms of schizophrenia suggests
a separate rnechanism underlying these symptoms.
In summary, the amygdala may generate depressed responses to its inputs (visual
cortex andlor midbrain), for any of several possible reasons (discussed in section 2 of this
discussion). Such a local imbalance in the rnodel circuit of figure 1 (page 158) could
generate many negative symptoms that are characteristic of schizophrenia. We suggest that
the rnost immediate effect of such a depressed response in emotion-representing areas is
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flat affect. This defect, in tum, may cause an inability to represent others’ beliefs and
intentions, in the sense that ail mental states that depend on interpreting one’s own
emotional state, or the emotional states of others, will be diminished. Most importantly, the
emotional experience itself will be lost because emotionally charged sensory inputs, such as
the emotional lAPS pictures presented to the patients in our study, activated the appropriate
parts of the visual cortex and midbrain but did not elicit an appropriate emotional response
in the amygdala and related ernotion-representing circuits. As a resuit, the prefrontal cortex
will not be adequately activated, and a hypofrontal condition will emerge (Weinberger
198$). Given a hypofrontal response, top-down signais from the prefrontal cortex to the
sensory cortices will also be reduced or elirninated. As a resuit, the sensory representations
will flot be able to use these top-down signals to organize information-processing according
to its emotional meaning. Consequently, emotional experience is lost.
1.5. Ihe Prefrontal cortex
Data reporting hypofrontality in schizophrenia date back to the elegant studies of
Ingvar and franzen (1974). Using the intracarotid xenon technique, the authors showed that
while nonschizophrenia subjects had the highest levels of blood ftow to anterior cortical
areas (which they tenned hyperfrontality), schizophrenia patients showed relatively
decreased frontal function. The interesting resuit from this study was that there was a
correlation between the degree of hypoftontality and negative symptoms. This finding has
been confirmed by Volkow and colleagues (1987), who reported that patients with more
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negative symptoms showed more severe hypofrontality (i.e., lower frontal cerebral glucose
metabolism as measured with positron ernission tomography) than did patients with fewer
negative symptoms. Further evidence of frontal cortex malfunction in schizophrenia
patients with major negative symptoms has corne from Owen and colleagues (1987). They
found an association between the clinical characteristics of flat affect patients clinical
characteristics and a decrease in monoamine oxidase-B concentrations in frontal and
temporal, as well as arnygdala, in comparison to patients without flat affect.
Our findings show that activity in the prefrontal cortex (BA 10; 47 and BA 32) is
modulated by emotional valence in the FA-. This is in une with results of some previous
neuroimaging studies (Gur et al., 2002; Davidson and frwin, 1999; Bechara et al., 1994;
Lévesque et al., 2003). Further evidence of the role of the mesial prefrontal (MPFC),
orbitofrontal (0FC), and anterior cingulate cortices (ACC) in voluntary emotional self
regulation (Lévesque et al., 2003; Beauregard et al., 2001), social leaming and in the
intemal representation of emotional experience (Arbib et al., 2000) was previously
demonstrated (Phan et al., 2002). 0f particular note, it is well established that damage
within the OMACC (orbitofrontal, mesial and anterior cingulate cortices) drarnatically
alters the capacity of higher mammals to cope ernotionally (Nauta, 1971; Mol! et al., 2002)
and socially (Bechara et al., 1994; Anderson et al., 1999) with different situations.
According to Phillips (2003), the information is conveyed to the prefrontal cortex for the
regulation of emotional experiences and behavior. This theory is in accordance with our
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coefficient correlation analysis of r=0.7 I between the midbrain and mesial prefrontal cortex
(analysis done using SPM99 and the matlab functions). On a related note, in a recent article
by Beauregard et al., (2001), the authors showed that the prefrontal cortex plays a role in
conscious and voÏuntary ernotional seif-regulation, where the information is accessible to
consciousness, thus providing an integrated perception of emotions. In sum, and of
relevance to our study, the arnygdala and prefrontal cortex are considered to be key nodes
of the neural circuit of ernotional processing, the former a main signal generator and the
latter a modulator (Davidson, 1999).
Overali, the cortical and subcortical areas we have discussed have rich
interconnections. None acts in a vacuum. Therefore, the functional anatomic modules that
mediate emotional experience are richlly interconnected and form a modular network.
Emotional experience depends on the pattems of neural activation of this modular network,
which we have seen is abnormal in fA+ ami seems to be similar to normal in FA-.
2. Cliuical and Biologïcal Implications
The conceptualization of the importance of understanding flat affect neurophysiology
has several implications. First, it is crucial to progress in etiologic and therapeutic research.
The clearest preonset signal of deterioration in schizophrenia is the appearance of
“prodromal” symptoms. According to Hafner and colleagues (1999), the first symptoms are
gradually developing nonspecific negative symptoms starting 3 to 5 years before onset,
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followed by positive symptoms around 1 year before onset of the disease. Here cornes the
importance of investigating flat affect. Second, understanding the neuropathology of flat
affect is of paramount importance, both to clinicians responsible for the care and treatment
of schizophrenia patients and to researchers who attempt to delineate the underpinnings of
schizophrenia neuropathology. The with flat affect/without flat affect distinction is
particularly crucial for studying emotional responding in schizoplirenia. Previous studies of
ernotional responding have likely included both with flat affect and without flat affect, who
may have different patterns of ernotional responding. Third, whether the social deficits are
the consequence of flat affect or vice versa have flot yet been investigated in schizophrenia
patients. Thus, elucidation of the inconsistency (between the findings of different studies),
constitute a critical step toward understanding the neural rnechanisms responsible for these
cognitive processes. Especially, since ernotional activity is at the heart of every
interpersonal interaction and is therefore of central importance for ail therapies and
reliabilitation strategies. 0f particular note, although schizophrenia is often characterized as
a heterogeneous disorder, efforts to validate stable and meaningful subtypes have met
limited success. Thus, the issue of whether schizopbrenia reflects a continuum of severity
or a nurnber of discrete subtypes remains controversial. Recent studies (Liddle, 1987;
Tsuang et al., 1990; Andreasen and Carpenter, 1993) reached the conclusion that
schizophrenia probably includes different diseases or reflects several dimensions of
psychopathology, each underlain by its own pathophysiology. from a genetic point of
view, this etiologic heterogeneity is one of the most likely explanations for the slow
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progress in the identification of susceptibility genes and consistent biological markers for
schizophrenia. There are likely multiple susceptibility genes. At least seven genes have
been proposed to be associated with schizophrenia (Harrison and Owen, 2003).
Distinguishing schizophrenia patients according to symptom presence or severity may be
one strategy for identifying such subtypes. Indeed, that there may be more than one
pathologic process in schizophrenia, each with its independent antecedents and
consequences, has been proposed (Crow, 1980b, Strauss et al., 1973).
Overail, investigating flat affect has implications for early detection, preventive
intervention, and future research. The aims of early detection are to identify subjects at high
risk of emotion abnormalities (e.g., flat affect). Hence, we need to focus preonset early
detection efforts flot just on those who are prodromally symptomatic (with positive
symptoms) but also on premorbid individuals who are at high risk for negative symptoms.
Barly interventions that reduce duration of untreated psychosis will improve lifetime
prognosis, and intervention in the prodrome will delay or prevent onset.
o
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3. Discussing Methodotogical Issues
3.1. Why choosing the Rating Scale for Emotional Blunting (RSEB) and the Calgary
Depression Scale (CDS)?
The RSEB is the only scale specifically measuring flat affect symptoms in
schizophrenia. It was developed by reviewing the literature ftom Pinel’s era (1801) to 1978
to determine clinical descriptions of emotional blunting. This constmct is ail that the scale
measures. Predictive validity, in this scale, was assessed by comparing total scores with
response to treatment; subjects with higher blunting scores showed a poorer response to
treatment (Abrams & Taylor, 197$). The RSEB includes four “indifference” items, three of
which are based on the patients’s self-report (lack of affection for family, unconcem for
own present situation, and unconcern for own future) and one of which is based on
observation (indifference to surroundings). Most importantly, it contains items describing
flat affect: absent, shallow, incongruous mood; constricted affect; unvarying affect (jacks
modulation, lacks warrnth and empathy); the patient is seclusive/withdrawn, and avoids
social contact. It must be emphasized that none of the prevailing concepts of negative
symptoms has been proven to have construct validity. We have attempted, as much as
possible, to approach flat affect construct validity by implementing the R$EB.
The distinction that Carpenter et al., (1985) made between primary and secondary
negative symptoms is pertinent. The authors stated that some negative symptoms are
secondary to positive symptoms or other consequences of the disease. for example social
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withdrawal could be a response to delusions or hallucinations. Such symptoms should be
distinguished from prirnary negative symptoms that are enduring and resistant to treatment.
In this vein, in a survey of 500 chronic institutionalized patients, Jolmstone anf Owens
(1980), demonstrated that negative symptoms may be unrelated to the presence of positive
symptoms. In this vin, we have attempted, as much as possible, to distinguish flat affect
symptoms from depression. To that end we have used the Calgary Depression Scale (CDS).
Furthermore, we have investigated the depression symptom on the PANSS and found no
significant difference between the two groups (F=0.43, t=-0.71, df=23, p=O.5). Our findings
show no significant difference between the two groups with respect to depression
symptoms, which suggest that flat affect symptoms are not secondary to depression in the
FA+. Interestingly, a schizophrenia patient with the deficit syndrome (mostly presenting
flat affect) and a schizophrenia patient who is depressed may have highly similar
presentations in terms of diminished ernotional experience. However, such patients show
highly different treatment responses. For example, the ernotional deficits of the depressed
schizophrenia patient would decrease in response to treatment with a selective serotonin
reuptake inhibitor (SSRT), while that of the deficit patient would remain unchanged
(Limpert and Amador, 2001).
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3.2. Why Choosing lAPS?
Our work supports cognitive theorists, who have been primarily concemed with
emotional experience. For example, the James-Lange (1884) theory of emotional
consciousness contends that perceptions (visual cortex) of an event produce specific
visceral (midbrain, insula, arnygdala and orbitofrontal cortex) pattems of arousal that resuit
in an emotional experience and modulation (prefrontal cortex) when perceived by the
individual. Furthermore, we should note that the experimental study of affect requires
quantitative stimulus tools to evoke affective states reliably in a laboratory setting, which is
quite a difficult task requiring validity and reliability. Toward that end, we have used the
litemational Affective Picture system (lAPS, Lang et al., 1997), a standardized and well
characterized collection of visual images designed to evoke either neutral, positive, or
negative emotional states. We used evocative pictures of negative/aversive and neutral
scenes with minimal cognitive demands so as to examine the automatic emotional response
that requires no elaborate rating or categorization of stimuli for the subjects. Facial
expressions do flot necessarily elicit strong ernotions, and cognitive demands sucli as
discriminating analogous facial expressions might affect brain activations (Critchley et al.,
2000). Findings (for example, Davis et al., 1995) show that mean dimensional self reports
of affective responses were highly replicable across cohorts. Mean categorical response
profiles for individual siides were also sirnilar across different cohorts and for different
experimental conditions. Valence calculated from weighted categorical self report scores
was highly correlated with the self reported valence (r +0.98), demonstrating a simple,
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linear relationship between dimensional and categorical (differential) measures of affect.
Categorical response strength was synergically pattemed, i.e. invariably correlated
positively for affect of the same dimensional valence and generally conelated negatively
for affect of opposite valence. facial electromyograms associated with affective responses
to siides were correlated with valence.
3.3. Why choosing a passive-viewïng method?
We deliberately chose a passive viewing method and avoided the use of a cognitive
task in conjunction with the presentation of the stimuli because of the known interactions
between cognition and emotion (Simpson et al., 2000). functional imaging studies have
corroborated the notion that the amygdala activation appears to depend on relatively
passive or implicit processing emotion, whereas requiring subjects to label the emotion can
instead resuit in deactivation (Hariri et al., 2000) and concomitant suppression of emotional
psychophysiological responses (Kapler et al., 2001). The reduction of amygdala responses
to emotional expressions, when the demand for explicit ernotion recognition is increased, is
a conmion observation across studies (Critchley et al., 2000) and may be rnediated by the
amygdala’s inhibition by frontal cortex. Furthennore, we presented stimuli for a relatively
short period (2.88 s) with no gap between in the images (in each block of the four negative
blocks). We hypothesize that the lack of a specific cognitive instruction together with the
brief presentation tirne profoundly influenced the activity in the midbrain and prefrontal
cortex. Poppel (1997) showed that it takes only 3 s to perceive a complex visual scene.
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When images are shown for a longer period, cognitive mechanisms that try to corne to an
alternative interpretation of the stimulus are elicited. 0f particular relevance to our study,
passive emotional tasks with minimal cognitive demands activate the amygdala and other
subcortical regions more often than emotional tasks with greater cognitive demands (Phan
et al., 2002). Thus, we successfully observed robust activation in widespread cortical and
subcortical regions as reported in previous studies (Lane et al., 1997a and Lane et al.,
1 997b).
3.4. Why choosing quetiapine?
Due ta the differences among antipsychotics available today, optimizing treatment for
individual patients requires choosing the most appropriate drng and, if necessary, switching
to a different drug if the first proves unsatisfactory. The treating physician must carefully
match the diverse needs of schizophrenia patients with the varied characteristics of the
second-generation antipsychotics. In this vein, negative symptoms, specifically blunted
affect, can be a part of the pathology of the disease (primary), or it can be secondary to
other syrnptom groups (e.g. positive, depressive, or EPS) of antipsychotic drugs. We
believe that a good approach for detecting whether antipsychotics have an improving effect
on primary negative symptoms is ta conduct studies among patients who are clinically
stable, with a high level of negative symptoms using an atypical with low EPS, because of
the known interaction with EPS and blunted affect.
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To that end we have chosen quetiapine. In an open-label extension phase of three double
blind randomized trials, quetiapine effectively controled schzophrenia symptoms for up to 3
years (Buckley et al., 2004). Moreover, quetiapine has a low risk ofEPS and appears to be
the only atypical antipsychotic without a dose-related increase in EPS (Gerlach, 2002). It
should be noted that the absence ofEPS is ofparticular relevance to our study, because we
o
wanted to control that the EPS symptoms are flot the cause of blunted affect. Furthermore,
the twelve study participants have already benn treated with other typical and atypical
antipsychotics. However, they were flot prescribed quetiapine before. Indeed, quetiapine
has been shown to be clinically effective in patients with only partial response to other
antipsychotic treatrnents (Emsley et al., 2000). Noteworthy, quetiapine’s relatively benign
tolerability profile distinguishes it from other commonly used atypical agents, with respect
to bodyweight, EPS and plasma prolactin levels (Buckley et al., 2004). Particulary,
quetiapine, like clozapine, show much lower D2 receptor occupancy in vivo than other
antipsychotics (Kapur et al., 2000). In this study, using PET, the authors showed that 12
hours after intake of the last dose, D2 receptor occupancy droped from 58%-64% (high
blockade) to 30%-40% (10w blockade). This low D2 occupancy probably reflects a more
rapid dissociation from the receptors than with other antipsychotics, which could account
for quetiapine’s low EPS.
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4. Limitations
The resuits of this thesis need to be considered in the context of several potential
limitations. First, while fMRT use is widespread, there is insufficient knowledge of the
physiological basis of the IIVIRI signal to interpret the data confidently with respect to
neural activity (Arbib et al. 2000). Logothetis and colleagues (2001) conducted the first
simultaneous intracortical recordings of neural signais and blood oxygenation level
dependent (BOLD) responses. The authors simultaneously scanned and recorded from
cortex in anesthetied monkeys, using fMRI and electrophysiological recording. The
monkeys viewed moving checkerboard pattems while electrodes pïaced in primary visual
cortex measured single- and multi unit neural spiking activity, as well as local field
potentials (LFPs), which reflect the dendro-sornatic inputs of the neural population.
Simultaneous fiviRi scanning was used to define a region of interest near the electrode tip
that showed a significant BOLD response to the stimulus. They found that the BOLD
response vas significantly correlated with the LFPs, which were stronger and more
sustained than the single- and multi unit neural spiking activity. These resuits indicate that
the BOLD signal does indeed reflect an increase in neurai activity.
Second, it should be noted that our task could be regarded as an emotion-induction
task. However, the finding needs to be interpreted cautiously because, strictly speaking, our
task was testing the access to autonoetic perception of elicited emotions. It might be
possible that the ability of schizophrenic patients to access their emotions (categorization of
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feeling) was different from that of normal controls. Our behavioral results might flot
necessarily reflect gut-level elicited emotion that drives emotional behavior. Autonomie
data such as skin conductance responses would help to measure gut-level emotional
response.
Third limitation is the use of a relatively srnall sample size, non-blind and open label
design of the quetiapine experiment. It is therefore difficult to ascertain whether the
differential brain activation was only due to quetiapine treatment or to the time difference
between the two scans. Further studies, using randomized, controlled and double-blind
methodology are needed to further investigate the potential effect of quetiapine in treating
flat affect/emotional withdrawal symptoms in schizophrenia.
5. Conclusion
In conclusion, these findings point to the existence of differential
neurophysiological rnechanisms in emotion processing between FA- and FA+, and a
recognition of the special roles played by different subcortical and cortical brain regions in
co-ordinating distinct strategies for processing emotions and hence, coping with different
types of negative reactions, stress, and threat. In summary, there is a differential
haemodynamic flow in key brain regions involved in emotion processing between
schizophrenia patients FA+ and FA-, which supports the heterogeneity model in
schizophrenia. This is not to say, of course, that it can accommodate the full diversity of
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schizophrenia, nor that it provides the same information as from biological and course
related measures and as from other phenornenological variables. Rather, as we have
proposed, better understanding of schizophrenia may require explanation of its various
guises and components. Most importantly, reporting quetiapine as a potential treatment for
flat affect symptoms in schizophrenia FA+ is of primordial importance due to fact that
these symptoms are the most debilitating, respond poorly to treatment and is considered
one of the most enduring symptoms. However, due to the small sample and methodological
concems over the reliability of the functional magnetic resonance imaging findings, these
resuits await further exploration and replication. We hope that we were able to provide
more focus on the dichotorny, present in the literature, concerning emotional deficits in
schizophrenia. Accordingly, arguments could be made that the continued search for specific
neural circuit abno?rnalities in schizophrenia shouÏd put aside the search for a “unitary”
neural circuit, and start searching for symptoms specific neural circuits, because no single
unitary model wiÏl likely justify the widespread functional and structural deficits of
schizophrenia. In this context, each symptom will have its own specific associated neural
circuit.
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